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Oral hairy leukoplakia (OHL) is an oral lesion that, prior to the advent of
AIDS in 1981, had not been reported in the literature.
ln 1984, Greenspan et al, described a white, non-removable lesion, which
they called oral "hairy" leukoplakia (OHL), which was confined to the lateral
borders of the tongue. OHL was associated in this initial report with both
papillomavirus and a herpes-type virus. lt was also observed that the
presence of this lesion was associated with progression of HIV disease in
many of the patients in the study. The imporlance of OHL as an indicator of
immunosuppression and prognosis of HIV disease was soon realised. lt is
included by the Centers for Disease Control in the 1993 Revised
Classification System for HIV lnfection and Expanded Case Surveillance
Case Definition for AIDS Among Adolescents and Adults.
ln the 13 years since the first description of OHL, many studies, primarily
from the United States and Europe, have investigated the lesion with
respect to aetiology and pathogenesis, histologic features and relevance to
HIV disease progression. A close relationship has been observed between
OHL and Epstein-Barr virus (EBV).
There has not been any Australian studies which have described, in detail,
the behaviour and characteristics of OHL in Australian HIV-infected
vil
patients. Anecdotal evidence indicated that OHL may not be as strong an
indicator of HIV progression or of immunosuppression in South Australian
patients as had been repofted by international studies
This research project was designed in two sections. The first paft of the
project comprised a retrospective analysis of OHL in 197 patients who had
attended the Medically Compromised Patient Unit of the Adelaide Dental
Hospital. The prevalence of OHL in these patients was examined with
respect to factors such as length of time of HIV infection, CD4+ T-
lymphocyte counts, AIDS-defining illness and concurrent medication. The
second, prospective analysis, of OHL examined the lesion in 20 patients
who had clinical evidence of the lesion. Exfoliative cytology smears from
OHL lesions of these patients were examined using light microscopy and
transmission electron microscopy.
The results from this project found that the prevalence of OHL in South
Australian patients was comparable to that found in international studies.
The presence of OHL was not related to CD4+ T-lymphocyte count or AIDS-
defining illness, nor did the length of time a patient had been infected with
HIV relate to the presence of OHL. An association was observed between a
reduced prevalence of OHL in patients taking the antiviral medications AZT
and aciclovir. The prevalence of oral Candida infection in relation to the
presence of OHL was not statistically significant.
vilt
The prospective analysis of OHL found that the clinical appearance of OHL
in the group of 20 patients was varied. lt could present as a smooth, flat
white lesion, to one that was corrugated and "shaggy". The size of the
lesions was not related to medication or CD4+ T-lymphocyte count. OHL
was observed to occur over a large range of CD4+ T-lymphocyte counts.
Examination of exfoliative cytology specimens revealed Candida infection in
25"/" of cases. The light microscopic appearance of squamous epithelial
cells did not reveal any marked changes in the morphology of the cells.
Ultrastructural examination of squamous epithelial cells demonstrated the
presence of herpes{ype viruses (consistent with EBV) within the cell nuclei
and extracellularly. Nuclear degeneration, as described in other studies,
was also observed, as was the presence of fungal organisms.
Generally, these results concur with those from other repofts in the literature
relating to OHL. These results do supporl the notion that OHL is not an
indicator of immunosuppression in South Australian patients, of course
longitudinal studies are required to asceftain the relationship of OHL to HIV
disease progression. Although supporting the possible role for EBV in the
aetiology of OHL, these results do not provide unequivocal support for EBV
as the sole aetiologic agent for the pathogenesis of OHL. The role of co-
factors in the pathogenesis of this lesion requires fufther investigation.
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Figure 1 The presence of oral hairy leukoplakia according to
the length of time since infection with HIV in study
subjects.
Figure 2 The proportion of subjects with oral hairy
leukoplakia with AIDS-defining illnesses and
without Al DS-defining illnesses.
Figure 3 The proportion of subjects with oral hairy
leukoplakia according to whether or not they are
taking medication.
Figure 4 The presence of oral hairy leukoplakia and its
association with AZT.
Figure 5 The presence of oral hairy leukoplakia and its
association with aciclovir.
Figure 6 The presence of oral hairy leukoplakia and its
association with CD4+ T-lymphocyte counts in
study subjects.
Figure 7 The presence of oral hairy leukoplakia and its
association with CD4+ T-lymphocyte count in study
subjects who had HIV infection for less than 5
years.
Figure 8 The presence of oral hairy leukoplakia and its
association with CD4+ T-lymphocyte count in study
subjects who had HIV infection for between 5 and
10 years.
Figure 9 The presence of OHL and its association with
CD4+ T-lymphocyte count in study subjects who
had HIV infection for greater than 10 years.
Figure 10 subjects with or without oral hairy leukoplakia and
the presence of oral Candida infection.
Oral hairy leukoplakia in a 30 year old HIV infected
male. lt presented as a small white corrugated






















Oral hairy leukoplakia in a 37 year old HIV infected
male. lt presented as a white corrugated lesion
which extended towards the ventral sudace of the
tongue where it had a smoother appearance.
Oral hairy leukoplakia occurring in a 25 year old
HIV infected male. The lesion presented on the
ventral aspect of the lateral border of the tongue
and had a smooth flat, thickened appearance.
Oral hairy leukoplakia occurring in a 35 year old
HIV infected female. The lesion presented as a
white, corrugated lesion on the lateral border of the
tongue.
Oral hairy leukoplakia in a 33 year old HIV infected
male. lt presented as a shaggy white lesion with a
corrugated appearance in some areas. lt was
located mainly on the lateral border of the tongue,
extending in some areas onto the dorsal and
ventral aspects of the tongue. Candida organisms
were found in association with the oral hairy
leukoplakia in this patient.
Exfoliative cytology smear from the lateral border
of the tongue. The features exhibited in this smear
are typical of those observed in all smears from all
subjects with oral hairy leukoplakia (H&E) Original
magnification x200
Exfoliative cytology smear from oral hairy
leukoplakia on the lateral border of the tongue
demonstrating fungal organisms (PAS) Original
magnification x200
Exfoliative cytology smear from oral hairy
leukoplakia on the lateral border of the tongue.
Squamous cells that have positive labelling for
EBV EA-D antigen are demonstrated (arrows).
Original magnification x400
Exfoliative cytology smear from oral hairy
leukoplakia on the lateral border of the tongue. A
group of EBV EA-D antigen positive cells is










Figure 20 Exfoliative cytology smear from oral hairy
leukoplakia on the lateral border of the tongue.
Occasional EBV EA-D antigen positive cells are
demonstrated (arrows). Original magnification x400
Figure 21 TEM of a squamous epithelial cell nucleus from an
exfoliative cytology specimen demonstrating herpes
type virus particles (small arrows) and margination
and clumping of the nuclear chromatin (large
arrows). Bar represents 500nm
Figure 22 TEM of squamous cells from an exfoliative cytology
specimen demonstrating fungal organisms (F) and
bacteria (B). Bar represents 2¡rm
Figure 23 TEM of squamous epithelial cells from an exfoliative
cytology specimen demonstrating herpes type virus
particles in the intercellular spaces (arrows). Bar
represents 500nm
Figure 24 TEM of a squamous epithelial cell from an exfoliative
cytology specimen demonstrating numerous herpes
type virus particles within the cell nucleus. Bar
represent 200nm
Figure 25 TEM of a squamous epithelial cell from an exfoliative
cytology specimen demonstrating herpes type virus
particles and aggregations of gold particles in the
nucleus of the cell (arrows). Bar represents 200nm
Figure 26 TEM of a squamous epithelial cell nucleus from an
exfoliative cytology specimen demonstrating herpes
type virus particles and aggregations of gold














AIDS defining illnesses that occurred within the group
and the number of study subjects with OHL and
without OHL according to each illness
The range of medication taken by study subjects and
the numbers of patients with OHL present according



















































Mycobacte ri u m avi u m complex
Normal horse serum
Oral hairy leukoplakia
Periodic Acid - Schiff
Phosphate buffered saline

























The first cases of Acquired lmmune Deficiency Syndrome (AIDS) were
identified in the United States in 1981 (Gottlieb etal, 1981; MMWR, 1981).
The first indication of this new disease was the diagnosis of Pneumocystis
cariniipneumonia (PCP) and Kaposi's Sarcoma (KS) in previously healthy,
homosexual men. The viral aetiologic agent for this syndrome was
eventually isolated in 1983 by both French and American investigators. lt
was shown to be a retrovirus and, in 1986, was named the Human
I mmunodeficiency Virus (H lV)
Oral manifestations as a result of immunosuppression due to HIV infection
have been widely repofted in the literature. The majority of people infected
with HIV experience oral lesions during the course of their disease
(Greenspan and Greenspan 1996).
Oral manifestations of HIV infection can be divided into four broad groups
according to their aetiology. These groups are:
1. Bacterial infections (for example, periodontal diseases)
2. Fungal infections (for example, oral Candida infections)
3. Viral infections (for example, herpes simplex infection)
4. Neoplastic lesions (for example, non-Hodgkins lymphoma)
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Many of these lesions have been reporled to have an atypical presentation
in patients who are infected with HIV (Greenspan and Greenspan, 1996)'
oral lesions may present with increased frequency and severity when
occurring in the context of Hlv infection. ln addition some oral
manifestations had not been described before the AIDS epidemic. An
example of such a lesion was oral hairy leukoplakia'
ln 1g84, Greenspan et al, reported this previously undescribed oral lesion in
Hlv positive, homosexual men. The white, non-removable lesion, which
they called oral "hairy" leukoplakia (oHL), was confined to the lateral
borders of the tongue. A high prevalence of candida was found in
association with oHL. More interestingly however, papillomavirus and a
herpes{ype virus were found in association with OHL. lt was also observed
that a proportion of the patients in the study developed A|DS-defining
illnesses within a relatively short time following the diagnosis of oHL.
The importance of oHL as an indicator of immunosuppression and
prognosis of HIV disease was soon realised. lt is included in the 1993
Revised classification system for Hlv lnfection and Expanded case
Definition for AIDS Among Adolescents and Adults (MMWR, 1992)
(Appendix l). The European Clearinghouse on oral problems related to HIV
infection and the WHO collaborating centre on the oral manifestations of the
immunodeficiency virus (EC-Clearinghouse, 1993) included OHL in its
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classification as a Group I lesion, that is, an oral lesion strongly associated
with HIV infection
Since its initial description, OHL has since been reported to occur in all risk
groups for HIV infection. ln rare cases, OHL has been identified in patient
groups who are immunosuppressed as a result of immunosuppressive
mechanisms other than HIV infection.
ln the 13 years since OHL was first repofted, many studies have
investigated the lesion with respect to aetiology and pathogenesis,
histologic features and relevance to HIV disease progression, There have
not been, however, any Australian studies which have described, in detail,
the behaviour and characteristics of OHL in Australian patients.
ln the following Chapter, the literature relating to OHL is reviewed. The first
section of the review examines clinical aspects of OHL, in pafticular its
prevalence in HIV-infected populations, its clinical appearance and
behaviour, its relationship to HIV disease and finally, its occurrence in HIV-
negative patients. The second part of the literature review relates to the
histological features of OHL, including the light microscopic and
ultrastructural appearances of the lesion. The majority of the literature
relating to OHL has concentrated on its aetiology and pathogenesis. This is
covered in the third section of the review. The last section of the literature
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review is concerned with diagnostic criteria and treatment modalities which
have been described in the literature.
ln the Australian context, there are questions relating to OHL which need to
be addressed. lt is unknown whether the characteristics of the lesion are the
same as has been described in the literature. ln addition, the role of OHL as
an indicator of HIV progression is unknown in Australian populations and
there are still questions relating to the aetiology and pathogenesis of the
lesion.
This analysis of OHL in a South Australian HIV-infected population was
carried out to gain more information on this lesion in the Australian setting.
The research project was designed, as described in Chapter 3, in two
sections, a retrospective and prospective analysis.
The retrospective analysis of OHL involved collecting information from the
case notes of H|V-infected patients who had attended the Medically
Compromised Patient Unit of the Adelaide Dental Hospital over an 8 year
period. lnformation was recorded which included the presence of OHL,
length of time of HIV infection, medication, AIDS-defining illnesses and
laboratory parameters such as CD4+ T-lymphocyte count.
ln the prospective analysis, 20 patients with clinical evidence of OHL were
examined. Exfoliative cytology specimens of OHL lesions were examined
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using light microscopy and transmission electron microscopy, ldentification
of EBV in the lesions was also achieved using immunohistochemistry.
Chapter 4 presents the results from the retrospective and prospective
analyses of OHL in this group of patients, These results are discussed and
appraised in relation to results from other studies of OHL in Chapter 5.






2. LITERATU RE REVIEW
2.1 Clinical res of Oral Hairv Leukoplakia
Oral hairy leukoplakia (OHL) has been extensively studied since its initial
description by Greenspan et al (1984), Knowledge of the features and
behaviour of this lesion, such as its prevalence in the Hlv-infected
population and its clinical appearance, is important in order to be able to
study its relevance to HIV disease'
2.1.1 Prevalence of Oral Hairy Leukoplakia
OHL was initially detected in San Francisco in a group of homosexual men
who were infected with HIV (Greenspan et a\,1984)' Since then, it has been
found to occur in all risk groups infected with HlV. These groups include
intravenous drug users (Ficarra et al, 1988; Barrone et al, 1990),
haemophiliacs (Rindum et al, 1987; Greenspan et al, 19894), blood
transfusion recipients (Greenspan et a/, 19894) and, occasionally, children
infected with HIV (Laskaris, Laskaris and Theodoridou, 1990; Leggott, 1992;
Itin et al, 1994).
OHL has also been repofted, albeit rarely, in HlV-negative patients, for
example in iatrogenically immunosuppressed patients (Birek et al, 1989;
Greenspan et al, 19898; Macleod, Lang and Soames, 1990; Schmidt-
Westhausen, Gelderblom and Reichart, 1990; Kanitakis et al, 1991;
Õ
Schmidt-Westhausen et al, 1991; Epstein, Sherlock and Wolber, 1993;
Schmidt-Westhausen et al, 1993)'
There are relatively large discrepancies in the reported prevalence of OHL
in HlV-infected populations around the world.
ln a group of 75 Dutch patients infected with HlV, 16% had OHL. However,
in this group, the prevalence of OHL in patients with AIDS was 21%
(Schulten, ten Kate and van der Waal, 1989). Another European study
found OHL to occur in 15"/" of patients infected with HIV (Porter et al, 1989).
ln 334 Hlv-1 seropositive African women, 0.4% were diagnosed with oHL
(Wanzala et a:,1989). Ramírez-Amador, Gonzalez and de la Rosa (1990)
reporled OHL occurring in 43"/" of a cohort of Mexican patients infected with
Hlv whereas ceballos-salobreña, Aguirre-urizar and Baga-Sebastian
(1996), reporled an oHL prevalence of 1 6.2% in an Hlv-infected spanish
population.
The variability in the prevalence of OHL is clearly based on factors such as
diagnostic criteria, characteristics of the patient cohorl (for example, age,
stage of HIV infection, access to health care) as well as clinical expertise in
diagnosis.
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2.1.2 Clinical appearance of Oral Hairy Leukoplakia
The possible prognostic significance of OHL in HIV infection and the fact
that it may be an early indicator of infection with HIV emphasises the
importance of distinguishing OHL from other fixed white lesions that can
occur in the mouth, particularly those involving the tongue.
A clinical differential diagnosis of white lesions of the tongue can include
leukoplakia, geographic tongue, frictional keratosis (for example, tongue
biting), lichen planus, and hyperplastic candidiasis (Green et al, 1989). ln
addition to thesej diagnoses, early squamous cell carcinoma should also be
considered.
OHL has relatively distinctive clinical features that need to be identified for
diagnosis. As its name suggests, OHL is a white lesion and is typically
found on the lateral borders of the tongue. The surface of the lesion varies
from smooth and flat, to a surface that is corrugated or "hairy" in
appearance (Greenspan et al, 1984; Schiødt et al, 1987; Williams et al,
1gg1). The sudace features of the OHL lesions may be influenced by the
site at which they occur on the tongue. Schiødt et al (1987) found that the
smooth flat lesions were more likely to occur on the ventral sudace of the
tongue whilst the corrugated or "hairy" lesions were usually found on the
lateral sudace of the tongue and occasionally, in severe cases, extended
onto the dorsal surJace.
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OHL is often found bilaterally (Schiødt et al, 1987; Schulten et al, 1992).
The size of the lesions is variable, ln the study by Schiødl et al (1987), it
was found that OHL lesions ranged in size from 1 4lo 42OO mm''
Apart from in the oral cavity, OHL has not been found on other mucosal
sudaces. There have been reports, however, of OHL occurring in other
areas in the mouth other than on the lateral border of the tongue.
lnvolvement of the buccal mucosa (Greenspan et al, 1984; Kabani et al,
1989; Ficarra et al, 1992), floor of the mouth, palate, retromolar areas,
tonsillar region and posterior pharyngeal mucosa have all been repofted
(Kabani et a\,1989).
Although originally considered to be a lesion that is relatively stable without
periods of remission, studies have shown that spontaneous resolution can
occur followed by recurrence (Katz et al, 1991). This may reflect factors
such as changing CD4+ T-lymphocyte count or viral load'
2.1.9 Correlation between Oral Hairy Leukoplakia and HIV disease
progression
The length of time from seroconversion to the development of severe
immunosuppression is of interest to both patients and their health care
providers. The use of clinical markers has become a convenient way of
monitoring a patient's immune status. Clinical markers have also served, in
some instances, as end points for clinical drug trials (Cooper et a\,1993)'
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Oral lesions such as OHL and oral candidiasis are common in patients with
HIV infection and have been investigated as to their prognostic significance.
OHL has also been shown by some studies to indicate increased likelihood
of HIV disease progression (Greenspan ef al, 1984; Coates et al, 1992) and
it is included in the Centers for Disease Control and Prevention (CDC)
classification of HIV infection (Appendix l).
As previously mentioned, the prevalence of OHL appears to be higher in
patients with AIDS compared with those patients who do not have any AIDS
defining conditions (Schulten et al, 1989). Many studies have recorded the
prevalence of OHL and concurrent indicators of immune function such as
CD4+ T-lymphocyte counts, HIV viral replication and p24 antigenaemia
(Glick et al, 1994; Kolokotronis et al, 1994; Lifson et al, 1994; Ravina et al,
1996), along with rates of progression to AIDS or death (Greenspan and
Greenspan, 1992).
OHL has been found to develop soon after HIV seroconversion and in
patients with a range of CD4+ T-lymphocyte counts (Lifson et al, 1994).
The prognostic value of OHL was initially reported by Greenspan et al
(1984), ln this initial description of OHL it was noted that 9 out of the 37
patients in the study had developed an AIDS defining illness, such as
Pneumocystis carinii pneumonia, within a 12 month period since diagnosis
of OHL lesions. ln addition to this, one patient in the study died from AIDS-
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related illness. Further studies by Greenspan ef al (1987), reinforced the
predictive value of OHL for the development of AIDS. Survival analyses
predicted that patients with OHL had a probability of AIDS developing of
48% within 16 months and 83% within 31 months.
Glick et at (1994) found that when OHL occurred in H|V-infected patients, it
could be identified at 24 months (median time) before the diagnosis of an
A|DS-defining illness and 41 months before death. Glick et al (1994),
calculated that the presence of OHL meant that the risk of having a CD4+
T-lymphocyte count below 200 cells/pl was 70.3%.
According to Glick et al (1994) and Begg et al (1996), the more oral
manifestations of HIV infection that are present in a patient, the higher the
probability of that patient having a low CD4+ T-lymphocyte count and a
poorer prognosls.
Kolokotronis ef al (199Q concluded that the presence of OHL combined
with immunological factors such as low circulating CD4+ T-lymphocytes and
loss of serum anti-p24 antibodies may indicate an increased likelihood for
progression to AIDS. OHL on its own, however, was not found to be
associated with an increased level of immunosuppression because the
presence of OHL did not increase as CD4+ T-lymphocyte counts decreased
(Kolokotronis ef al, 1994). Ravina et al(1996) also found that the presence
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of OHL was associated with compromised immunological factors and higher
viral replication which was indicated by p24 antigenaemia.
Although they are relatively scarce, such studies indicate that the use of
OHL as a clinical marker may be as useful as markers such as CD4+ T-
lymphocyte levels in predicting progression to AIDS.
OHL may also be a useful clinical marker to help determine whether or not
anti-retroviral therapy should be stafied. According to Schiødt ef a/ (1990),
the use of clinical indicators are important in situations (for example, in
underdeveloped countries) where expensive diagnostic tests such as viral
load are not feasible.
2.1.4 Oral Hairy Leukoplakia in HIV-negative patients
HIV infection is not the only cause of immunodeficiency. Other causes may
include primary immunodeficiencies, lymphoproliferative diseases and
iatrogenic suppression of the immune system by immunosuppressive
medication required to prevent rejection of transplanted organs.
Radiotherapy and chemotherapy used in the treatment of neoplastic
disease can also contribute to immunosuppression. Consequently, OHL
may be a clinical feature that is seen in other types of immunodeficiency.
OHL has been reported in patients who have had renal transplants
(Greenspan et a\,19898; Macleod et al, 1990; Kanitakis ef al, 1991), heart
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transplants (Schmidt-Westhausen ef a/, 1990; Schmidt-Westhausen et al,
1991), liver transplants (Schmidt-Westhausen ef a/, 1993) and bone marrow
transplants (Birek et al, 1989; Epstein et al, 1993). With the exception of
one report (Epstein et al, 1993), each case of OHL was shown to be
associated with Epstein-Barr virus.
Epstein et at(1993) studied lesions resembling OHL in ten patients who had
undergone bone marrow transplantation. EBV could be demonstrated in
lesions of only three of these patients and two out of the three also
demonstrated human papilloma virus (HPV) by in sifu hybridisation. The
presence of histological features such as acanthosis, koilocytosis and
hyperparakeratosis could not discriminate between lesions associated with
EBV or HPV.
Syrjänen et al (1989) reported a case of OHL in a patient undergoing
chemotherapy for acute myeloblastic leukaemia. The lesion was detected
prior to bone marrow transplantation. EBV was identified in the lesion by the
use of in situ hybridisation.
Other instances of OHL that were not associated with HIV infection have
been described in patients taking systemic steroids. Reports have included
an asthmatic patienl (Zakrzewska, Aly and Speight, 1995), a patient with
Behçet's syndrome (Schiødt, Nørgaard and Greenspan, 1995) and two
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patients who had been treated with topical steroids for oral vesiculobullous
disease (Lozada-Nur, Robinson and Regezi, 1994)'
The asthmatic case reported by Zakrzewska et a/ (1995) is interesting
because the lesion suspected to be OHL was associated with a severe
episode of pseudomembranous candidiasis which was thought to be
precipitated by the cofticosteroid therapy. The "OHL" was treated with
Nystatin initially, followed by ketoconazole which also proved to be
ineffective. Although EBV was identified in the tongue lesions by in situ
hybridisation, the lesions described as OHL ultimately responded to
antifungal treatment with flucon azole.
Lesions which respond to antifungal treatment are generally not considered
to be OHL. While it may be possible that the candidiasis in the previous
case repoft (Zakrzewska et a/ 1995) was a cofactor in the development of
OHL, it has been demonstrated that Candida albicans is not associated with
all cases of OHL (Reichart et al, 1989). lt can be speculated, however, that
Candida could be a co-factor in more cases of OHL than have previously
been reported.
OHL has been repofted, albeit rarely, in patients who have been shown to
be immunocompetent (McMillan et al, 1989; Eisenberg, Krutchkoff and
Yamase, 1992; Felix ef al, 1992; Lozada-Nur et al, 1994)'
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Felix ef al (1992) reported OHL occurring in an elderly man who had no
evidence of HIV infection or clinical immunodeficiency. The patient's CD4+
T lymphocyte count was only 364 cells/pl, a level that is consistent with the
development of OHL in patients who have HIV infection. The percentage of
CD4+ T lymphocytes cells (out of the total lymphocyte count), however, was
44"/o, which is within the normal range. This case possibly supporls the view
of Eisenberg et al (1992) who surmised that OHL is not necessarily
indicative of immunosuppression, but rather, represents a localised and
transient infection of the epithelium.
latrogenic immunosuppression is relatively common in the general
population, it is surprising, therefore, that the prevalence of OHL in these
patients is not proporlional. ln order to account for this, Greenspan et al
(19898) proposed that existing leukoplakias in patients receiving
immunosuppressive drugs are initially devoid of EBV' The
immunosuppression allows EBV to be expressed and to replicate within
these lesions. Although this is one explanation which accounts for the rarity
of the lesion in HIV negative patients, there is no evidence that OHL should
develop differently in H|V-infected patients. Apart from misdiagnosis in HIV
negative patients, this may indicate that other factors are involved besides a
suppressed immune sYstem.
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2.2 Histopatholoqv of Oral Hairv Leukoplakia
The histopathological features of OHL have been well documented. The
initial report of the lesion by Greenspan et al (1984) described OHL as
having a similar histologic appearance to that of flat wafts of the skin. Since
1gB4 numerous studies have been performed on OHL lesions using both
light and electron microscoPY.
2.2.1 Light microscopic features of Oral Hairy Leukoplakia
Greenspan et al (1984) described the histologic features of OHL in 35
specimens taken from 30 patients. All of the biopsies, taken from the lateral
border of the tongue, showed hyperparakeratotic acanthotic epithelium. ln
some areas, the keratin formed projections which gave the appearance of
hairs on the epithelial sudace. The cells of the prickle cell layer
demonstrated féatures resembling koilocytes which are characterised by
ballooning changes in their cytoplasm and pyknotic nuclei with perinuclear
halos. The subepithelial connective tissue showed a minimal or, in most
cases, no inflammatory cell infiltrate.
Some authors have objected to the use of the terms "koilocytosis" and
"koilocytes" in reference to the ballooning, vacuolated keratinocytes found in
the prickle cell layer of the epithelium of OHL (Kanas et al, 19884; Syrjänen
et al, 1989). According to Kanas et al (1988A) these terms should be
restricted to lesions which are caused by human papilloma virus. Syrjänen
et al (1989) described the differences between true koilocytes found in HPV
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infection and those in OHL. True koilocytes have enlarged nuclei that result
in an increased nuclear to cytoplasmic ratio. ln OHL the nuclei of these cells
are small. Kanas et at (1988), compared koilocytes found in flat
condylomatous lesions of the cervix (FCLC), which are associated with
HPV, and the cells found in OHL using light microscopy and
immunohistochemistry. ln addition to increased nuclear to cytoplasmic ratio,
the cells in OHL were less extensively vacuolated compared with FCLC.
The latter also showed features of nuclear pleomorphism such as
multinucleated nuclei.
Other studies (Schøidt et al, 1987 Kanas et al, 1988; ltin and Rufli, 1990)
have reported similar histologic features of OHL to that described by
Greenspan et al (1984). Schiødt et al (1987) presented a more detailed
description of the histologic spectrum of OHL. Again, parakeratosis,
acanthosis, vacuolated cells and hair-like projections of keratin were the
prominent features of these lesions. Although there were Candida hyphae
present in the epithelium of 43"/" of Schiødt's specimens, no leukocytes
were found in the epithelium or in relation to the hyphae' As would be
expected, the histologic appearance of the OHL corresponded to its clinical
appearance. For example, the lesions that were flat clinically usually lacked
the characteristic keratin projections at the epithelial surface. Vacuolated
cells were found mainly in the superficial part of the prickle cell layer'
OHL lesions are typically reported as not showing any signs of dysplasia or
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premalignancy. However, apart from epithelial hyperplasia which is a
recognised histological feature of OHL, minor atypia has been repofted
including hyperchromatism and increased mitoses of the basal layer (Glick
and Pliskin, 1990).
Scuibba et at (1989) found that many of the superficial cells of OHL lesions
had dense aggregations of nuclear chromatin adjacent to the nuclear
membrane. lt was suggested that this appearance was similar to the
Cowdry type inclusions which are a typical feature of cells infected with
herpes viruses. Other studies have also described these inclusions in
superficial cells of OHL lesions by examination of exfoliative cytology
specimens (Fraga-Fernández and Vicandi-Plaza, 1992; Migliorati et al,
1ee3).
The presence of other cell types in OHL, particularly Langerhans cells, has
also been studied (Daniels et al, 1987; Cruchley ef a/, 1989; Riccardi et al,
1gg0). Langerhans cells play an important role in the cell mediated immune
system and are involved in the processing and presentation of antigens
(Barret, Crutchley and Williams, 1996).
Regional variation of Langerhans cells in the oral mucosa has been
reporled in various studies (Daniels, 1984; Cruchley et al, 1989).The lateral
border of the tongue normally has small areas, ranging from 0.2 - 0.5mm in
diameter, where Langerhans cells are absent (Daniels et al, 1987). Cruchley
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et al (1989) found that the lateral border of the tongue was an area in the
oral cavity, along with the hard palate and floor of the mouth, that normally
has reduced numbers of Langerhans cells when compared with other areas
in the oral cavity.
Daniels et at(1987) found that Langerhans cells are absent or considerably
reduced in numbers in OHL lesions, and postulated that this may be a factor
in the development of OHL by allowing viral replication within the cells of the
epithelium because of a reduced local immune response. Corso, Eversole
and Hutt-Fletcher(1989), also found a marked reduction in the number of
cells that stained for S-100 in OHL. This was determined by comparing cell
counts per high-powered field in 10 cases of OHL with cell counts in 10
cases of normal lateral tongue mucosa. lt is unknown, however, whether the
absence of Langerhans cells precedes the development of OHL or occurs
subsequent to the development of the lesion.
Patterns of keratin expression in OHL have been studied using
immunohistochemistry and in situ hybridisation in order to elucidate the
behaviour of the lesion and compare it with other white lesions that occur in
the mouth (Williams et al, 1991 ; Langford ef al, 1992; Su ef a/, 1993)'
Su ef a/ (1993) found comparable levels of keratin 14, a major cytokeratin
that is found in the basal layer of stratified squamous epithelium, between
normal control oral mucosa and OHL lesions using immunohistochemistry.
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In situ hybridis4tion, however, demonstrated a decrease in the level of
keratin 14 mRNA in OHL. This may be a consequence of the increased
sensitivity of in situ hybridisation compared with immunohistochemistry or
simply reflect the increased stability of cytokeratin proteins compared with
mRNA (Su ef a/, 1993).
Langford et al (1992) found that cytokeratins 10 and 1 1 were increased in
the epithelium of the lateral border of the tongue of HIV positive patients
compared with levels in epithelium from HIV negative patients. These
cytokeratins are considered markers for keratinisation and are not normally
expressed in noh-keratinising epithelium (Langford et al, 1992). This study
found that irrespective of the clinical presence of OHL, there is an increase
in keratinising cells in the lateral border of the tongue in HIV positive
patients. ln addition, it was reported that there appeared to be no correlation
between the types of cytokeratins expressed in the epithelium of the lateral
border of the tongue and the clinical presence of OHL lesions.
Williams et at (1991)found that expression of keratins 6, 16 and 19 were
markedly reduced in OHL. Keratin 19 has been associated with a
premalignant potential in epithelia because its presence indicates delayed
terminal differenìiation of epithelial cells. Keratins 6 and 16 are related to
epithelia with a high turnover, their absence indicating decreased turnover
of the epithelium, thereby resulting in acanthosis which is a characteristic
histologic feature of OHL. Other keratins such as 5 and 14 were expressed
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similarly between OHL and controls. The combination of these facts relating
to cytokeratin expression possibly indicates a low premalignant potential for
OHL which is in accordance with the histologic features of the lesion.
It should be noted that the "characteristic" features of OHL can also be seen
in some cases in normal tongue epithelium. Andersen, Philipsen, Reichart
(1990) looked at the normal anatomy of the lateral border of the tongue and
found that features mimicking hyperplasia, acanthosis, and keratin
projections could be demonstrated depending on which way the tissue was
sectioned. Andersen et al (1990) also reported cells that could be
interpreted as koilocyte-like cells in association with filiform papillae'
2.2.2 Electron microscopic features of Oral Hairy Leukoplakia
Several ultrastructural studies of OHL have been completed since 1984
(Greenspan et al, 1984; Belton and Eversole, 1986; El-Labban et al, 1988;
Reed, Fowler and Brannon, 1988; Zhang et al, 1988; Sciubba et al, 1989;
Greenspan et al, 1989; El-Labban et al, 1990). The initial ultrastructural
descriptions of OHL by Greenspan et al (1984) concentrated on the
presence of viral particles both within the nuclei of the prickle cells and
intercellularly. These viral particles had the appearance of a herpes-group
virus. This feature was confirmed by subsequent investigations (Reed et al,
1988; Zhang et al, 1988; Greenspan et al, 1989C)'
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Virions have been found in various stages of development and scattered
throughout the nucleus (Belton and Eversole, 1986). They have also been
seen budding from the nuclear envelope which is thickened at these
locations (Belton and Eversole, 1986).
Other ultrastructural features of the epithelium correlate with those observed
using light microscopy.
Ballooned keratinocytes or koilocyte-like cells are a characteristic feature in
the prickle cell layer of OHL. Ultrastructural studies indicate that they
contain only a few organelles including degenerated mitochondria and
abundant intermediate sized keratin fibrils (Zhang et al, 1988). These
authors noted two characteristic features occurring within the cytoplasm of
the virus infected keratinocytes. The first consisted of 35nm tubules that
were arranged in bundles 1pm in length. The other structure was composed
of "undulating and convoluted membranes", 25nm in width, associated with
the nuclei of the koilocytes. lt was suggested that these structures may
represent tubuloreticular precursors. Tuboreticular structures have been
identified in variqus tissues in patients with AIDS-related complex and AIDS
along with other immunological and neurodegenerative diseases. lt is
possible that they may be an indicator of interferon production which is
consistent with a viral aetiology for OHL.
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El-labban et al (1988) reported two types of crystalline inclusions within the
cytoplasm of the epithelial cells of OHL. One structure consisted of
microtubules associated with an electron dense body. The other was an
elongated multivesicular structure. The vesicles were of similar size to the
herpes-type virions that were also present within the cells. lt was suggested
that these represented an abnormal form of microtubule within the epithelial
cells or that the multivesicular structures may, in some way, be related to
the viruses within the cell.
Foci of condensed chromatin are also found in keratinocytes along with
infestation of the epithelium wilh Candida. Candida organisms have been
found extracellularly, within the cytoplasm and, in some cases, within the
nucleus (Belton and Eversole, 1986).
Ultrastructural studies of biopsies confirmed that Langerhans cells are
absent in these lesions (Zhang et al, 1988; Riccardi et al, 1990), a feature
that is consistent with the findings of light microscopic examination.
Fufthermore, no evidence of inflammatory cells were noted within the
lesions.
Sciubba et a/ (1989) described the ultrastructural morphology of the
superficial cells of OHL lesions. The nuclei of the superficial cells were
flattened, had a "ground glass" appearance and clusters of chromatin were
distributed radially inside the nuclear envelope. Although Sciubba et al
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(1989) eliminated the possibility of the presence of human papillomavirus
(HPV) in OHL lesions by using Southern blot analysis, the presence of EBV
was demonstrated. There was also no morphological evidence for the
occurrence of HPV within the lesions.
Ultrastructural examination of exfoliative cytology specimens has also been
performed (Kratochvil et al, 1990; Epstein et al, 1995). ln these studies,
herpes-type viriqns were observed within the cells and in the intercellular
spaces. Kratochvil et al (1990) also observed bacterial colonisation and
fungal hyphae associated with the keratinocytes. ln both studies the cells
had few organelles, a feature consistent with their derivation from superficial
layers of the epithelium. The ease of collecting exfoliative cytology
specimens and the demonstration of herpes{ype virions within the cells
makes this a useful, non-invasive technique for the diagnosis of OHL.
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2.3 The oloov and pathooenesis of ral Hairv Leukoo akia
The identification of an aetiologic agent for the development of OHL has
been a goal since the lesion was first described. OHL is often found in
association with Candida (Glick and Pliskin, 1990). The strong association
of the lesion with the Epstein-Barr virus has resulted in the need for the
identification of this virus for the definitive diagnosis of OHL (Williams ef a/,
1ee2).
2.3.1 Candidaand Oral Hairy Leukoplakia
lnfections with Candida in the mouth have become increasingly more
common as a result of immunodeficiency due to HIV infection. Candida
albicans is the most common species ol Candida that is found in the oral
cavity (Scully, El-Kabir and Samaranayake, 1994).
Candidahas frequently been isolated in OHL. ln the initial reported cases of
OHL, Candida was found in 26 out of 37 cases (Greenspan et al, 1984)'
Other studies have also found a high prevalence of Candida associated with
OHL (Schiødt et at, 1987) and ultrastructural studies have demonstrated
Candida present in the superficial layers of the epithelium (Zhang et al,
1e88).
The question of whether or not candida plays a role in the aetiology and
pathogenesis of OHL has been considered because of the frequent finding
of fungal organisms within the lesions'
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Changes in the epithelium are consistent findings associated with oral
Candida infection. An example where epithelial changes are obserued is
chronic hyperplastic candidiasis. The histologic features of this condition
include a parakeratotic, hyperplastic and acanthotic epithelium, features
also found in OHL lesions. Clinically, the lesions appear as white or
speckled areas which do not rub off (Reed et al, 1990). The organisms are
confined to the üpper layers of the epithelium. lt has been postulated that
the thickening of the epithelium is a physiologic protective response to
mechanical and chemical damage caused by the fungal organisms (Nagai,
Takeshita and Saku, 1992).
lncreases in epithelial cell mitotic activity by products of C. albicans have
also been demonstrated (Reed et al, 1990). These authors proposed that
Candida products could have a direct effect on epithelial cells, although the
exact factor responsible was not isolated nor identified. C. albicans
produces a wide variety of enzymes which may have an effect on epithelial
cells.
Clinically, the role oÍ Candida as the aetiologic agent in the development of
OHL lesions is not supported. Topical or systemic antifungal medication
does not result in a resolution of OHL. Hence, it is unlikely that Candida is a
sole aetiologic agent in the development of OHL. lt is more probable that
the conditions that are created by the presence of OHL produce a suitable
environment for the opportunistic infection of the epithelium by Candida.
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2.3.2. Viruses and Oral Hairy Leukoplakia
The initial description of OHL repofted that the ultrastructural appearance of
the lesion demonstrated two types of virus (Greenspan et al, 1984). Human
papillomavirus was identified using immunocytochemistry and a herpes-type
virus was seen at the ultrastructural level. Greenspan et al (1984),
suggested that OHL may be a result of a dual infection by the two viruses.
Since this initial study, the evidence for human papilloma virus in OHL has
been conflicting. The herpes-type virus has been consistently found in OHL
lesions and subsequently demonstrated to be Epstein-Barr virus
(Greenspan et al, 1 985).
2.3.2.1 Human Papilloma Virus
Human papilloma viruses (HPV) belong to the family Papovaviridae of which
there are over 70 members (Miller, 1995). Each type of HPV appears to
have a preference for infecting specific epithelial sites. "High risk" types of
HPV that are implicated as the aetiological agents of cervical squamous cell
carcinomas are 16, 18, 31,45 and 54 (Laimins, 1996). HPV types 6 and 11
have been associated with genital wafts, lesions that are considered to have
a low malignant potential (Kumar et al, 1992; Laimins, 1996).
HPV has also been implicated in numerous oral lesions including oral viral
warts, focal epithelial hyperplasia (Heck's disease), oral squamous cell
carcinoma, lichen planus and OHL (Chang et a\,1991).
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The evidence for HPV in hairy leukoplakia is conflicting. Greenspan et al
(1984), in their initial report of OHL, found evidence of HPV. lt was also
demonstrated in a subsequent study in which HPV was detected by electron
microscopy and immunocytochemistry in 73% of biopsy specimens
(Greenspan et al, 1985).
Eversole et al (1986) found no evidence of HPV by ultrastructural
examination of OHL lesions. However immunocytochemistry demonstrated
HPV in 14"/" of koilocYte nuclei.
Adler-Storthz et al (1992) found HPV DNA corresponding to HPV types 16
and 18 in ten out of eighteen biopsies of OHL by the use of polymerase
chain reaction amplification. ln three of the cases the type of HPV was of an
unknown type and not 6, 1 1, 16 or 18. Overall, the predominant type of HPV
that was found in this study was type 16. lnterestingly, however, HPV was
also found regularly in clinically normal buccal mucosa in this HIV positive
patient sample. This may indicate that the presence of HPV is not an
important factor in the development of OHL, but merely a reflection of the
patient's immune status. Felix ef a/ (1993) carried out a similar study and
found no evidence of HPV 16.
Resnick et at(1988) attributed their inability to detect HPV in OHL lesions to
sampling factors, stating that the detection of HPV from verrucae can also
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vary between tissue specimens. This could account for the variation in the
detection of HPV in OHL lesions in different studies.
2.3.2.2 Epstei n-Barr Virus
Epstein-Barr virus has been reported to infect up to 90% of the world's
population (Thomas et al, 1991; Luxton et al, 1993). lt is the aetiologic
factor in a spectrum of diseases including infectious mononucleosis,
nasopharyngeal carcinoma and Burkitt's lymphoma. lnfection with EBV
usually occurs during childhood as a subclinical infection. Although EBV can
be reactivated in many people, the reactivation "infection" is most often
subclinical (Baskin et a|,1995)
Like other members of the herpes virus family (Appendix ll), after an initial
primary infection, the EBV establishes a persistent, lifelong infection in the
host. These healthy seropositive people occasionally shed low levels of
EBV particles in oropharyngeal secretions (Thomas et al, 1991). The
reservoirs of latently infected cells are thought to be epithelial cells and
circulating B cells. Wolf, Haus and Wilmes (1984) demonstrated EBV
persistence in the parotid gland. Normal tongue epithelium (that is, not
associated with OHL or HIV) does not appear to be a natural reseruoir for
EBV in immunocompetent people even if serology testing indicates past
EBV infection (Miller et a\,1994).
Two types of Epstein-Barr virus are recognised, type A and type B. Various
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strains of each type of EBV can also be found. ln vitro, types A and B differ
in their ability to transform B lymphocytes. Type B EBV infected B
lymphocytes grow poorly in culture (Kieff , 1995).
EBV has been detected in biopsy specimens of OHL using electron
microscopy (Reed et al, 1988; Sugihara et al, 1990), immunocytochemistry
(Kanas et al, 1988; Mabruk et al, 1996; Murray et al, 1996), polymerase
chain reaction (Adler-Storilhz et al, 1992; Felix et al, 1993) and in situ
hybridisation (De Souza et al, 1990; Cubie, Felix and Wray, 1991; Mabruk
et al, 1994; Mabruk ef al 1996). EBV DNA has also been found in clinically
normal tongues sampled at autopsy from AIDS patients (Mabruk et al,
1 ee5).
Walling et al(1995), examined patients with OHL lesions not associated
with HIV infection and consistently found EBV coinfection and
recombination. Raab-Traub and Webster-Cyriaque (1 997) detected multiple
strains of EBV within OHL lesions. These authors found that recombination
of EBV occurred during viral replication resulting in the generation of new
EBV variants. These reports suggested that viral determinants may be more
important factors in the development of OHL than immune status.
ln OHL, EBV appears to be confined to the upper epithelial cell layers
(Murray et al, 1996). There is currently no evidence to show a latent
infection of EBV'within the basal cell layers of the epithelium (Niedobitek ef
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al, 1991; Crutchley et al, 1997). lt is suggested by some authors that the
EBV is sustained within the more differentiated layers of the epithelium by
continual reinfection as they could not find any evidence of latent infection
within the basal or suprabasal layers. This distribution of viral infection
corresponds to the location of receptors for EBV in the epithelium (Corso ef
a{ 1989). This receptor is the same as the receptor for the C3d fraction of
complement and it is also expressed by B-lymphocytes (Sixbey et al, 1987).
The epithelial phenotype may play a role in the development of OHL
lesions. Corso et al (1989) found that only the upper and middle cell layers
of parakeratinised epithelia express the EBV/C3d receptor and that this
receptor was absent in orthokeratinised gingival and hard palate epithelia.
Although the latter observation has been offered as an explanation for the
absence of OHL development on the hard palate and gingiva, the validity of
such an argument is debatable when considering that orthokeratinised
epithelium is an uncommon finding in the oral cavity.
EBV has been shown to cause changes in epithelia and may play a role,
like HPV, in carcinogenesis (Miller et al, 1994). EBV has been shown to
prevent epithelial cell differentiation (Dawson, Rickinson and Young, 1990)
and also to cause hyperplastic lesions in mice (Wilson et al, 1990). These
features may provide support for the role of EBV in the hyperplasia
observed in OHL lesions.
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Risk factors that influence EBV replication in oral epithelial cells have been
investigated. Boulter et al (1996) found that antifungal treatment and
avoidance of ciggrette smoking may reduce the likelihood of development of
OHL in HIV positive individuals. They also observed that EBV replication
reduced as CD8+ T-lymphocytes (suppressor cells) increased. This
indicates that the aetiology and pathogenesis of OHL is possibly
multifactorial rather than the result of a sole aetiologic agent.
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2.4 The diaqnosis and manaqement of Oral Hairv Leukoplakia
The accurate diagnosis of OHL, is imporlant for the following reasons:
OHL, in some cases, may be an early indicator of HIV infection (Lifson ef
a\,1994)
The development of OHL in a patient with known HIV infection may have
prognostic implications for that patient (Greenspan and Greenspan,
1992; Kolokotron is et al, 1 994; Ramírez-Amador, Esquivel-P edraza and
Ponce de León , 1996)
staging of Hlv disease is influenced by the presence or absence of oral
manifestations including OHL (Cruz ef al 1996)
o
a
The EC-Clearinghouse update of the classification and diagnostic criteria of
oral lesions in HIV infection outlined both presumptive and definitive criteria
for the diagnosis of Hlv infection (EC-Clearinghouse, 1993).
presumptive criteria for the diagnosis of OHL are the presence of bilateral
white or grey lesions on the lateral border of the tongue. Definitive criteria
for the diagnosis of OHL are the demonstration of the presence of Epstein-
Barr virus within the lesions or, in cases where this is not possible, a lack of
response to antifungal treatment. An immunedeficient status also provides
weight to a diagnosis of OHL'
ln most instances, presumptive criteria arc usually adequate for the
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identification of this lesion (except perhaps when definitive OHL criteria are
required for specific studies, such as a clinical end point in drug trials).
Various techniques for the definitive diagnosis of OHL (that is, detection of
EBV) have been investigated. These have included the use of electron
microscopy of exfoliative cytology specimens (Kratochvil ef al, 1990;
Sugihara et al, 1990; Fraga-Fernandez and Vicandi-Plaza, 1992; Migliorati
et al, 1993; Miller et al, 1994; Epstein et al, 1995), immunohistochemistry
(Zhang et al, 1988) and in situ hybridisation (Mabruk et al, 1996).
OHL is an oral manifestation of HIV infection which usually requires no
treatment. lt is generally asymptomatic and there has been no reported
evidence of any premalignant potential of the lesion. Patients may
occasionally complain of slight discomfort or of a "burning" sensation
(Schöfer et al, 1987; Greenspan and Greenspan, 1989D; Greenspan and
Greenspan, 1996). This burning sensation, in some cases, may also be a
feature oÍ a Candida inlection superimposed on the OHL. Up to 5O"/" of
lesions have been found to harbour Candida albicans (Glick and Pliskin,
1990). This can be resolved with antifungal treatment.
Treatment may 
, 
occasionally be requested by patients, for example, for
widespread lesions which may pose an aesthetic concern.
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Various methods have been used to treat OHL including both systemic and
topical medication
The beneficial effect of systemic antiviral medication on OHL supports the
view that the main aetiologic agent for OHL is viral. Medication such as
aciclovir is successful in eliminating or reducing the size of the lesions
(Schöfer et al, 1987; Glick and Pliskin, 1990; Scully, Porter and Luker,
1991; Barr, 1994). However, once this treatment is stopped, recurrence of
the lesion is a common event (Schöfer et al, 1987; Resnick et al, 1988;
Greenspan and Greenspan, 1996). Greenspan and Greenspan (1989),
used a drug, desiclovir, which is similar to aciclovir, with some success.
However recurrence of the lesions was also a feature of this treatment when
cessation of the drug occurred. OHL lesions have also been shown to
resolve wlren patients have started to take antiretroviral medication such as
Zidovudine (AZT) (Phelan and Klein, 1988; Greenspan and Greenspan,
1989; Barr, 1994).
Side effects are occasionally encountered with aciclovir such as nausea,
vomiting, diarrhoea and headache (Mims Annual, 1994). This may
contraindicate the use of this and similar drugs to treat OHL (Glick and
Plisken, 1990; Gowdy et al, 1995). In addition, resistance to aciclovir can
occur (Epstein and Scully, 1991; Mims Annual, 1994; Gowdy et al, 1995)
complicating the treatment of other, more serious opportunistic infections in
immunocompromised Patients.
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Various topical medications have been employed to reduce OHL or relieve
symptoms associated with the lesion. Topical retinoids, such as vitamin A
acid (0.1%), applied twice a day has been used in some trials, however the
lesions recurred soon after cessation of the medication (Schöfer et al, 1987;
Gowdy et al, 1995). Retinoids act as dekeratinising agents by causing
changes in patterns of epithelial cell differentiation (Mims Annual, 1994).
Another topical medication employed for the treatment of OHL is
podophyllum resin (Lozada-Nur and Costa, 1992; Gowdy, Lee and
Carpenter, 1995). This compound is an extrad of Podophyllum peltatrum, a
plant found in the northern and middle United States. lt has been used in
the past for the treatment of dermatologic diseases caused by human
papillomavirus infection such as verrucae and condyloma acuminatum. lt
inhibits cell mitosis in metaphase because of its high affinity for a protein
found in microtubules of the mitotic spindle (Lozada-Nur and Costa, 1992;
Gowdy et al, 1995). For the treatment of OHL, podophyllum resin is applied
directly to the lesion for a period of 30 to 60 seconds after which the
patients rinse their mouths with water. Lozada-Nur and Costa (1992), found
remissions in OHL for up to 28 weeks with very few side effects
encountered.
ln the majority of patients OHL is a lesion that only requires periodic
monitoring as to its presence. Unless requested by patients, active
treatment of the lesion is not indicated.
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2.5 Conclusions
OHL has been extensively studied since its first description in 1984 by
Greenspan et al. The range of clinical and histological appearances of this
lesion are well ,documented. Despite this information, 
however, several
questions remain relating to various aspects of the lesion including:
o the exact role that EBV plays in the pathogenesis of OHL
. the possible role of co-factors in the development of OHL
. the reason why OHL lesions are located predominantly on the lateral
border of the tongue
ln addition, the use of OHL as a clinical indicator of HIV disease progression
is an area that needs further investigation. Anecdotal evidence derived from
the patients infected with HIV who attend the Adelaide Dental Hospital
suggest that the presence of OHL may not be as accurate a reflection of
HIV disease progression as that previously described in some studies from
the United States and Europe. This fact, however, has not been
demonstrated experimentally.
There have not been any detailed Australian studies which have described
the behaviour and characteristics of OHL in Australian HIV-infected
patients.
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This study of OHL in H|V-infected patients at the Adelaide Dental Hospital
was undeftaken in order to:
. collect information regarding the occurrence of OHL in an HIV infected
Australian population
o collect information correlating the presence of OHL to other systemic
conditions and laboratory parameters such as CD4+T-lymphocyte count,
It is hypothesised that the presence of OHL is not strongly correlated with
CD4+T-lymphocyte counts in South Australian patients, and accordingly,
its presence is not an indicator of poor prognosis
o detect the presence of EBV in OHL lesions of an Australian population
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3. MATERIALS AND METHODS
This research project was designed in two sections
Retrospective analysis of oral hairy leukoplakia:
A retrospective analysis of 197 patients infected with HIV who had attended
the Medically Compromised Patient Unit of the Adelaide Dental Hospital.
lnformation such as estimated time since conversion, date of diagnosis of
HIV infection, CD4+ T-lymphocyte counts, current medication and previous
or concurrent AIDS-defining medical conditions was acquired from entries in
the patients' case notes and were correlated to the presence or absence of
OHL.
Prospective analysis of oral hairy leukoplakia:
A prospective analysis of a group of 20 patients with OHL who attended the
Medically Compromised Patient Unit of the Adelaide Dental Hospital. This
section of the study was aimed to correlate features occurring concurrently
with OHL such as CD4+ T-lymphocyte count, medication and concurrent
systemic medical conditions.
The clinical appearance of the lesions consistent with OHL was described.
ln addition, this section of the project aimed to provide definitive criteria for
the diagnosis of OHL, that is, the demonstration of Epstein-Barr virus (EBV)
in the lesions.
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The project was undeftaken with the approval of the University of Adelaide
Committee on the Ethics of Human Experimentation, approval number
H|29194.
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3.1 Retros analvsis of Oral Hairv Leukoolakia
Data was collected from patient records gf the Adelaide Dental Hospital.
The information was obtained from records of 197 HIV positive patients
attending the Medically Compromised Unit from January 1986 to February
1 995.
Patients were referred to the unit for dental management from a variety of
sources, principally private medical practitioners, the Royal Adelaide
Hospital and the Flinders Medical Centre.
The information that was recorded at each patient's visit included estimated
time since HIV seroconversion, the date of diagnosis, CD4+ T-lymphocyte
counts, current medication and any AlDS-defining illnesses that they may
have had. All of this information was provided by the patients and by
consultation with their referring medical practitioners.
For the purpose of this study, data derived from records was manually
transferred to proformas (Appendix lll) and subsequently analysed as
follows:
prevalence and site of OHL
presence of OHL and length of time since infection with HIV
presence of OHL and AIDS-defining illness






o presence of OHL and CD4+ T-lymphocyte count
. presence of OHL and oral Candida infection
OHL was defined according to the EC-Clearinghouse-WHO criteria (EC-
Clearinghouse, 1993). Medical conditions were classed as AIDS-defining
conditions according to the 1993 Revised Classification System for HIV
infection and Expanded Surveillance Case Definition for AIDS Among
Adolescents and Adults (MMWR, 1992). Statistical analysis of the data was
done using the chi squared test,
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3.2 Prospective analvsis of Oral Hairv ukoplakia
A total of 20 patients were involved in the study. They were selected on the
basis that lesions resembling OHL were clinically apparent. OHL was
defined according to the presumptive diagnostic criteria outlined in the EC-
Clearinghouse classification of oral manifestations of HIV infection (EC-
Clearinghouse, 1993).
One patient was included who had a lesion resembling OHL on his hard
palate. OHL has been reported to occur in areas other than the tongue
(Kabani et al, 1989).
Patients were given an information sheet (Appendix lV) and asked to
consent to participate in the study (Appendix V).
3.2. 1 Clinical examination
Patients with OHL were examined and details relating to the lesions
recorded. This included the site and size of the lesions. Other clinical
information was obtained such as CD4+ T-lymphocyte count, medication
and concurrent systemic medical conditions.
Clinical photographs of the OHL lesions were taken with a Pentax SFXn
camera, using Kodachrome'64 ASA (Kodak Eastman, USA), 35mm film.
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3.2.2 Exfoliative cytology smears
Exfoliative cytology smears were taken from the areas of the tongue
involved by the OHL lesions. A total of five smears were taken from each
lesion. The patient's tongue was held using a piece of gauze whilst the
lesion was gently scraped using a blunt spatula.
The spatula was then run along a glass microscope slide which was allowed
to brief ly air dry before being placed in 10% formalin for f ixation. The slides
were fixed for 60 minutes.
One smear was stained with Haematoxylin and Eosin (H and E) according
to the procedure outlined in Appendix Vl.
Two smears were stained with Periodic acid-Schiff (PAS) to determine the
presence of fungal organisms in the lesions. This was done according to the
procedure outlined in Appendix Vll.
The remaining two smears were used for immunohistochemical studies in
order to determine the presence of EBV in the lesions. This was required for
a definitive diagnosis of OHL according to EC-Clearinghouse-WHO criteria
(EQ-Clearinghouse, 1993). The exfoliative cytology smears were labelled
with two monoclonal antibodies specific for EBV, latent membrane protein
(LMP-1, Dako-EBV, CS 1-4) and the diffuse early antigen (EA-D,
NovoQastra, NCL-EADE31). The positive controls consisted of paraffin
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sections from a specimen of a previously confirmed EBV-positive case of
Hodgkin's Lymphoma. lmmunohistochemical labelling of the exfoliative
cytology smears was carried out by Dr K. Smith, lnstitute of Medical and
Veterinary Sciences, Adelaide, according to the procedure that is outlined in
Appendix Vlll.
3.2.2.1 Light microscopY
H and E stained, PAS stained and immunohistochemistry specimens were
all examined using the an Olympus CHK-F microscope. They were
photographed using the PM-1OADS Olympus Automatic Photographic
system. The film used was Kodachrome'64 ASA (Kodak Eastman, USA),
35mm film.
3.2.2.2 Electron microscopy
lnitially, cytology samples from the lesions were investigated using electron
microscopy to determine the morphology of the cells and the presence of
viruses within the lesion. Plain electron microscopy and immunogold
labelling of ultrathin sections was carried out by Dr. P. Smith, lnstitute of
Medical and Veterinary Sciences, Adelaide. Furlher smears were taken for
future immunogold labelling studies in order to attempt to identify the
viruses that were found within the epithelial cells.
For electron microscopy, Smears Were taken from the tongue according to
the procedure outlined previously. lnstead of smearing glass microscope
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slides, however, the spatulas were rinsed with a solution of 1%
glutaraldehyde in O.05M sodium cacodylate buffer. The suspension of cells
within the fixative was prepared for electron microscopy according to the
procedure outlined in Appendix lX.
After embedding, 0.5pm survey sections were cut and dried on a glass slide
before being stained with 0.1% Toluidine Blue. Ultrathin sections were then
cut using a Sorvall Porter-Blum Ultramicrotome. They were then picked up
on a copper grid and stained with alcoholic uranyl acetate and lead citrate.
For immunogold labelling studies using a monoclonal antibody specific for
the diffuse early antigen (EA-D, NovoCastra, NCL-EADE31), the spatulas
were rinsed in 0.5% glutaraldehyde in phosphate buffered saline (PBS) and
the suspension was fixed for t hour before preparation and embedding in L.
R. White resin (Appendix X). The procedure for immunogold labelling of the
exfoliative cytology smears is outlined in Appendix Xl.
lmmunogold labelling of the exfoliative cytology specimens was carried out
on 2 specimens in this study as a pilot investigation to ascertain the
effectiveness of the technique as a basis for future immunogold studies. As
a consequence no controls were used in this instance.
All of the ultrastructural examinations of the sections was done using the
JEOL 12OO EXll electron microscope (80 kV).
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For the purpose of this study, data derived from clinical and histological
examination was manually transferred to proformas (Appendix Xll). Data
was subsequently analysed as follows:
o gerìerâl features of OHL
. association between OHL and concurrent systemic medical conditions
and medication
. association between the size of OHL lesions and CD4+ T-lymphocyte
count
. light microscopic and transmission electron microscopic examination of






4.1 Ret tve analvsis of Oral Hai rv Leuko akia
Data was gathered f rom records of 197 patients who had attended the
Medically compromised unit of the Adelaide Dental Hospital.
The group of 197 patients was composed of 186 (94'4%) males and 11
(5.6%) females. The mean age of the group was 36.9 years (range 19 - 67
years). One hundred and eighty one patients were male homosexuals'
thirteen patients (2 male, 11 female) had a known history of intravenous
drug use and three patients (all male) had haemophilia.
Thirty nine patients died during the period January 1986 to February 1995
4.1.1 Prevalence and site of Oral Hairy Leukoplakia
Clinical evidence of OHL was seen on the lateral border of the tongue in 89
patients (45.2%).ln 40 (44.9%) of these cases, oHL was bilateral'
ln 3 patients, OHL was also reported in the case notes to occur on the
buccal mucosa. These three patients also had bilateral OHL lesions on their
tongues.
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4.1.2 Presence of Oral Hairy Leukoplakia and the length of time since
infection with HIV
Seventy six patients had been infected with HIV for less than or equal to 5
years, and, of these, 36 (47.4o/o) had OHL present. Eighty five patients had
been infected with HIV for more than 5 years and less than 10 years
previously, and, of these, 33 (38.8%) had OHL present. Thirty six patients
had been infected with HIV for more than 10 years, and, of these, 20
(55.60lo) had OHL present (X2=3.116, O.1O<P<0.05 (Chi squared analysis))
(Figure 1).
Figure l: The presence of oral hairy leukoplakia according to the length of time



























4.1.3 Presence of Oral Hairy Leukoplakia and AIDS-defining illness
One hundred and sixty one patients had no AIDS-defining medical condition
recorded in their dental records. Of these, 70 (43.5%) had OHL lesions
present.
Thirty six patients had an AIDS-defining illness recorded in their case notes
(Table 1). These A|DS-defining illnesses included, Pneumocystis carinii
pneumonia (PCP), Mycobacterium avium complex (MAC), Tuberculosis
(TB), Cytomegalovirus infection (CMV), Herpes simplex virus infection
(HSV), Cryptococcal infection, Aspergillus infection, Kaposi's sarcoma (KS)
and Lymphoma. Seventeen patients (51.5%) patients in this group had OHL
(X2=O.O74, P>0.5 (Chi square analysis)) (Figure 2).
54










Table 1: AIDS-defining illnesses that occurred within the group and the number











































Figure 2: The proportion of patients with oral hairy leukoplakia w¡th AIDs-defining
illnesses and without AIDS-defining illnesses
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4.1.4 Presence of Oral Hairy Leukoplakia and concurrent medication
One hundred and fifty eight patients were taking medication (Table 2). This
medication included antiviral drugs (Zidovudine (AZT), Didanosine (ddl),
ZalciTabine (ddO), Stavudine (d4T), Aciclovir and Ganciclovir), antifungal
drugs (Fluconazole, Ketoconazole and ltraconazole) and antibacterial drugs
(Ethambutol, Rifampicin, Clofazamine, Clarithromycin, Trimethoprim and
Sulfamethoxazole combinations and Pentamidine). Of these, 77 (48.7%)
had OHL (X2=4.076, 0.02<P<0.05 (Chi squared analysis)) (Figure 3)'
There were 39 patients who were not taking any medication, of these 30.8%
had OHL which is low compared with the overall prevalence of OHL (45.2%)
in the study
One hundred and thirty patients were taking antiviral medication. Of these,
91 were taking AZT and of these, 27 (29.7%) had OHL compared to 62
(58.5%) patients who were not taking AZT and had OHL (X2=1 6.420,
0.001<P<0.01 (Chi squared analysis)) (Figure a).
Forty nine patients were taking aciclovir, of these, 14 (28.6%) had OHL
compared with 75 (50.7%) patients who were not taking aciclovir and had
OHL (X2=7.262,0.001<P<0.01 (Chi squared analysis) (Figure 5).
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Figure 3: The proportion of subjects with oral hairy leukoplakia accord¡ng to


















































Figure 5: The presence of oral hairy leukoplakia and ¡ts association with aciclovir
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4.1.5 Presence of Oral Hairy Leukoplakia and CD + T-lymphocyte
count
CD4+ T-lymphocyte counts were recorded in case notes of 150 of the 197
patients. The numbers of CD4+ T-lymphocytes in patients with OHL ranged
from 0 - 1200 cells/pl (mean 294.01 cells/pl). ln patients without OHL, the
CD4+ T-lymphocyte counts ranged from 0-2200 cells/pl (mean 376.99
cells/pl).
The patients were divided into 3 groups according to CD4+ T-lymphocyte
count, namely CD4+ T-lymphocyte counts <200 cells/¡rl, 200-500 cells/pl
and >500 cells/pl. Fifty three patients had CD4+ T-lymphocyte counts less
than 200 cells/pl, of these 27 (50.9%) had OHL. Fifty six patients had CD4+
T-lymphocyte counts between 200 and 500 cells/pl, of these 26 (46/%)
had OHL. Forly one patients had CD4+ T-lymphocyte counts above 500
cells/pl, of these 15 (36.6%) had OHL (X2=1.966, 0.1<P<0.5 (Chi squared
analysis)) (Figure 6).
The estimated length of time since HIV seroconversion was less than 5
years in 50 patients. ln this group, the mean CD4+ T-lymphocyte count was
303.14 cells/pl in patients with OHL, compared with 400.18 cells/pl in
patients without OHL. Eighteen patients had CD4+ T-lymphocyte counts
below 200 cells/pl, of these 11 (61.1%) had OHL. Sixteen patients had
CD4+ T-lymphocyte counts between 200 and 500 cells/pl, of these g
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(56.3%) had OHL. Sixteen patients had CD4+ T-lymphocyte counts above
500 cells/pl, of these 8 (50%) had OHL (X2=O.425, P>0.5 (Chi squared
analysis)) (Figure 7).
The estimated length of time since HIV seroconversion was between 5 and
1O years in 70 patients. ln this group, the mean CD4+ T-lymphocyte count
was 404.03 cells/pl in patients with OHL compared to 385.21 cells/pl in
patients without OHL. Twenty three patients had CD4+ T-lymphocyte counts
below 2OO cells/pl, of these 7 (30.4"/") had OHL. Twenty six patients had
CD4+ T-lymphocyte counts between 200 and 500 cells/pl, of these 10
(38.5%) had OHL. Twenty one patients had CD4+ T-lymphocyte counts
greater than 500 cells/pl, of these 6 (28.6"/") had OHL (X2=1 '122, P>0.5
(Chi squared analysis)) (Figure 8).
The estimated length of time since HIV seroconversion was greater that 10
years in 30 patients. ln this group, the mean CD4+ T-lymphocyte count was
174.85 cellspl in patients with OHL compared to 345.60 cells/pl in patients
without OHL. Twelve patients had CD4+ T-lymphocyte counts below 200
cells/pl, of these 9 (75%) had OHL. Fourteen patients had CD4+ T-
lymphocyte counts between 200 and 500 cells/pl, of these 7 (50%) had
OHL. Four patients had CD4+ T-lymphocyte counts greater that 500
























Figure 6: The presence of oral hairy leukoplakia and its association with CD4+

























Figure 7: The presence of oral hairy leukoplakia and its association with CD4+






























Figure 8: The presence of oral hairy leukoplakia and its association with CD4+
T-lymphocyte count in study subjects who had HIV infection for






























Figure 9: The presence of OHL and its association with CD4+ T-lymphocyte
count in study subjects who had HIV infection for greater than 10
years
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4.1.6. Presence of Oral Hairy Leukoplakia and Candida
A total of 53 (26.9%o) patients in the sample of 197 had some form of oral
Candida infection. Out of this group of patients, 28 (52.8o/o) had OHL
present, whilst 25 patients (47.2o/o) had no evidence of OHL. (X2=1.714,
0.1<P<0.5 (Chi squared analysis)) (Figure 10).
The prevalence of oral Candida infection in the group of 89 patients with
OHL was 31.5o/o (*=0.62{ P>0.5 (Chi squared analysis)).



























4.2 Prospective analvsis of Oral Hairv Leukoolakia
The group of 20 patients in this section of the project comprised 19 males
and 1 female. All patients were infected with HlV, 4 patients (3 male and 1
female) had a history of intravenous drug use. The remaining patients were
homosexual men. The average CD4+ T-lymphocyte count for this group of
patients was 324 cells/pl (range 14 - 1000 cells/pl). All patients had white,
non-removable lesions on their tongues that were consistent with oral hairy
leukoplakia.
4.2.1 General features of Oral Hairy Leukoplakia
The clinical features of OHL that were seen in this group of 20 patients were
variable. Seven patients had bilateral lesions occurring on the tongue. The
average area of the tongue covered by the lesions was 509mm2 (3-
24}omm2).
ln some cases the OHL that was observed was mild. This form of OHL was
characterised by a slight thickening of the lateral border of the tongue
forming a slightly corrugated surface. More severe forms of OHL observed
presented as white, "shaggy" lesions which often extended beyond the
lateral border of the tongue including, in some cases both the dorsal surface
of the tongue and floor of the mouth. The range of clinical appearances of
OHL that was observed in the study subjects is illustrated in Figures 11 to
15.
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Figure 11 Oral hairy leukoplakia in a 30 year old HIV infected male. lt
presented as a small white corrugated area on the lateral border of
the tongue
Oral hairy leukoplakia in a 37 year old HIV infected male. lt
presented as a white corrugated lesion which extended towards the
ventral surface of the tongue where it had a smoother appearance






Figure 13 Oral hairy leukoplakia occurring in a 25 year old HIV infected male.
The lesion presented on the ventral aspect of the lateral border of
the tongue and had a smooth flat, thickened appearance
Oral hairy leukoplakia occurring in a 35 year old HIV infected
female. The lesion presented as a white, corrugated lesion on the











Figure 15: Oral hairy leukoplakia in a 33 year old HIV infected male. lt
presented as a shaggy white lesion with a corrugated appearance in
some areas. lt was located mainly on the lateral border of the
tongue, extending in some areas onto the dorsal and ventral aspects
of the tongue. Fungal organisms were found in association with the
oral hairy leukoplakia in this patient.
72
One patient in the study had a white, non-removable lesion present on his
hard palate. Although not a typical site for the presentation of OHL, this
lesion was unresponsive to antifungal therapy and resolved in response to
antiretroviral treatment. lt was therefore included as a possible atypical
presentation of OHL.
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4.2.2 Relationship between the size of Oral Hairy Leukoplakia lesions
and concurrent systemic medical conditions and medication
None of the patients, at the time of having cytology smears taken from their
tongues, had any concurrent systemic medical conditions.
Eight patients were not taking any medication. Ten patients were taking
some form of antiretroviral medication (AZT, ddl, ddC, 3TC, d4T). Five
patients were taking aciclovir. The mean area of the lesions for patients who
were taking antiviral medication was approximately 333.3ffiffi2, whilst the
area of OHL lesions in patients not on any medication was approximately
277.78mm2.
Six patients were also taking prophylactic medication for Pneumocystis
carinii pneumonia (Sulfamethoxazole/Trimethoprim combinations such as
Bactrim or Septrim). One patient was taking fluconazole and one patient
was taking methadone.
4.2.3 Association between the size of Oral Hairy Leukoplakia lesions
and CD4+ T-lymphocyte count
The average CD4+ T-lymphocyte count for the group oÍ 20 patients was
323.65 cells/pl (range 14-1000 cells/pl). The average size of the lesions
according to CD4+ T-lymphocyte count was 338.83mm2, 372.5mm2 and
363.25mm2 Íor CD4+ T-lymphocyte counts <2OO cells/pl, 200-500 cells/¡rl
and >500 cells/pl respectively.
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4.2.4 Exfoliative cytology smears
Exfoliative cytology smears taken from the lateral border of the tongue were
examined using both light and electron microscopy.
4.2.4.1 Light microscopy
Tongue smears were initially stained with Haematoxylin and Eosin (H and
E). This was done for two reasons, initially it was to determine whether
adequate numbers of cells could be obtained by scraping the tongue for
future electron microscopic analysis. Additionally H and E demonstrated
cytological features of the superficial epithelial cells. Additional smears were
stained with Periodic acid - Schiff (PAS) to detect the presence of fungal
organisms.
4.2.4.1.1 Haematoxylin and Eosin Stain
Haematoxylin and eosin staining of the cytology smears demonstrated a
large number of cells in each specimen (Figure 16). All smears exhibited
relatively bland cytologic features consisting mainly of superficial squamous
cells with small, dark staining nuclei. Nuclear to cytoplasmic ratios were
consistent between cells and between different patients. ln occasional cells,
margination of the nuclear material was observed. No cytoplasmic or
nuclear inclusions were seen in any of the smears.
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Figure 16: Exfoliative cytology smear from the lateral border of the tongue. The
features exhibited in this smear are typicar of those observed in all
smears from all subjects with oral hairy leukoplakia (H&E) original
magnification x200
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4.2.4.1 .2 Periodic Acid-Schiff Stain
The squamous cells stained with PAS stained an intense purple colour. ln 5
(25%) of the 20 patients, fungal pseudohyphae and spores were seen
(Figure 17).
Figure 17: Exfoliative cytology smear from oral hairy leukoplakia on the lateral




Exfoliative cytology smears were available from thirteen of the twenty
subjects. All of the smears were negative for the latent membrane protein
(LMP-1) antigen. Eight smears had positive labelling for the diffuse early
antigen (EA-D) (Figure 18). Three smears were negative for the EA-D
antigen and two smears had insufficient numbers of cells present to provide
conclusive evidence. Only a small fraction of the cells in the positive smears
demonstrated positive labelling for EBV using the EA-D antibody. ln some
smears, the cells were relatively numerous (Figure 19). In other smears,
only occasional positive cells were observed (Figure 20).
Figure 18 Exfoliative cytology smear from oral hairy leukoplakia on the lateral
border of the tongue. Squamous epithelial cells that have positive












Figure 19: Exfoliative cytology smear from oral hairy leukoplakia on the lateral
border of the tongue. A group of EBV EA-D antigen positive cells is
demonstrated (arrows). Original magnification x400
Exfoliative cytology smear from oral hairy leukoplakia on the lateral
border of the tongue. Occasional EBV EA-D antigen positive cells are








































4.2.4.2 Transmission electron microscopy
lnvestigation of the ultrastructural features of the superficial squamous cells
associated with OHL was carried out to determine whether the technique of
scraping the tongue provided adequate material for TEM examination.
4.2.4.2.1 Cellular morphology
Twelve patients had material collected for ultrastructural investigation. ln the
case of 3 of these patients insufficient material was collected for TEM, and
the samples were discarded.
ln the remaining 9 specimens, characteristic features were seen. The cells
had a fibrillar cytoplasm relatively devoid of organelles consistent with
superficial squamous epithelial cells.
The nuclei of the cells had degenerated and all of the squamous cells in the
cytology specimens demonstrated "clumping" and margination of the
chromatin in the nuclei to some degree (Figure 21). ln some cases the
nuclear membrane appeared to be absent.
Fungal organisms were demonstrated in four of the specimens by
ultrastructural examination. Fungal elements were observed both
intracellularly and extracellularly (Figure 22).
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Numerous herpes-type virus particles were seen in the nuclei of the some of
the epithelial cells from 7 of the study subjects. When present, they made
up the bulk of the contents of the nuclei and appeared to be at various
stages of development. Virus particles were also observed intercellularly
(Figure 23). The herpes-type virus particles had a mean diameter of 92nm









TEM of a squamous epithelial cell nucleus from an exfoliative cytology
specimen demonstrating numerous herpes type virus particles (small
arrows) and margination and clumping of the nuclear chromatin (large




Figure 22: TEM of squamous cells from an exfoliative cytology specimen





TEM of squamous epithelial cells from an exfoliative cytology
specimen demonstrating herpes-type virus particles in the






TEM of a squamous epithelial cell from an exfoliative cytology
specimen demonstrating numerous herpestype virus particles
within the cell nucleus. Bar represents 200nm
Figure 24
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4.2.4.2.2 U ltrastructural im munogold labelling
Ultrastructural immunogold labelling of squamous epithelial cells from
exfoliative cytology samples from OHL lesions was performed on 2
specimens using the monoclonal antibody specific for the EBV diffuse early
antigen (EA-D). This was done as a pilot investigation to ascertain the
effectiveness of the technique with a view to underlake more
comprehensive immunogold labelling studies in the future. Both specimens
had numerous herpes-type virions present in the nuclei of the epithelial
cells. Gold particles were found to be restricted to the nuclei of the epithelial
cells and in some cases found to be aggregated around virus particles
(Figures 25 and 26).
B6
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TEM of a squamous epithelial cell from an exfoliative cytology
specimen demonstrating herpes-type virus particles and aggregations




Figure 26: TEM of a squamous epithelial cell nucleus from an exfoliative cytology
specimen demonstrating herpes-type virus particles and aggregations






The availability of South Australian data relating to the oral manifestations of
HIV infection is limited. A study of the social impact of oral conditions
among H|V-infected dental patients in South Australia was reported by
Coates et al (1996). This study concentrated on clinical dental indices such
as the number of decayed, missing and filled teeth (DMFT) and the
community periodontal index of treatment needs (CPITN).
The present study provides additional, more specific information on oral
hairy leukoplakia in relation to its behaviour and the association of OHL with
systemic features of HIV disease. Retrospective and prospective sections of
this study are discussed separately.
5.1 Retrosoective analvsis Oral Hairv Leukoolakia
Since its initial description by Greenspan et al (1984), OHL has been
studied with respect to its relationship to various clinical parameters
associated with HIV infection. These clinical features have included the
length of time since HIV seroconversion, CD4+T-lymphocyte count,
medication and AIDS-defining illness.
OHL attracted attention early on in the global HIV epidemic because of its
potential significance as a prognostic factor for HIV infection. lts presence,
as suggested by Greenspan et al (1984), was thought to herald the
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progression to AIDS or even death. Other international studies have since
found OHL to be a marker of immunosuppression and progression of HIV
disease (Greenspan et al, 1987; Kolokotronis et al, 1994; Begg et al, 1996;
Ceballos-Salobreña et al, 1996; Ramírez-Amador et al, 1996).
It should be noted that the information from the retrospective analysis in the
present study is based solely on the information contained in the patients'
casenotes. The information in the clinical records, although comprehensive,
was subject to variation. At least 3 dentists were involved in the
management of H|V-infected patients throughout the period January 1986
to February 1995. ln addition, the medical information was based on that
obtained from a variety of sources (for example, different medical
practitioners) which may have further influenced the information in the
patient records.
Also, the diagnosis of OHL was based on presumptive criteria as outlined by
the EC-Clearinghouse, WHO criteria (EC-Clearinghouse, 1993). This
diagnostic criteria requires that the lesions are white and present on the
lateral border of the tongue. ln some cases the lesions can extend onto the
ventral and dorsal surfaces of the tongue and, in Some cases, involve the
buccal mucosa.
Definitive diagnosis of OHL requires the demonstration of EBV within the
lesions, or, where this is not possible, a lack of response to antifungal
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treatment can add weight to a presumptive diagnosis. lt was not always
evident by examination of the casenote entries whether antifungal treatment
was employed to differentiate lesions.
5.1.1 Intraoral location of Oral Hairy Leukoplakia
OHL was originally described by Greenspan ef a/ (1984) as a fixed, white
lesion that occurred on the lateral border of the tongue. ln the present study,
the clinical findings in relation to the predominant site of occurrence of OHL
were in accord with the descriptions of a number of investigators from a
variety of countries.
Schiødt et at (1987) found that in a sample of 50 patients, OHL occurred
exclusively on the lateral border of the tongue. ln that group of patients,
86% had OHL occurring bilaterally. ln the present study, bilateral OHL was
not observed as frequently as this. Only 44.9"/" of our patients had OHL
occurring bilaterally on their tongues. There are two explanations for this
difference, firstly, it may be that there were inaccuracies in the diagnosis of
OHL in both the present study and in the study by Schiødl et al. Secondly,
the presence of OHL in patient records may have been under-reported.
Aparl from the possibility of a real difference in the clinical presentation of
OHL between the two studies, the differences may be a reflection of the
difference in sample sizes. The present study may give a more accurate
picture of the clinical presentation of OHL because of the greater number of
subjects in the study.
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Other studies have observed more extensive involvement of the oral cavity
by OHL (Kabani et al, 1989; Ficarra et al, 1992). These studies have
described OHL occurring on the buccal mucosa, floor of the mouth, palate
and dorsal surface of the tongue. OHL was found on the buccal mucosa in
3 patients in the present study. Although an interesting clinical feature from
a diagnostic point of view, it has been shown that the severity of OHL (that
is, the extent of intraoral involvement), as opposed to its presence does not
seem to be predictive for immunosuppression or for the development of
AIDS in patients infected with HIV (Schiødt et a\,1987).
5.1.2 Prevalence of Oral Hairy Leukoplakia and time since infection
with HIV
The most common oral manifestations of HIV infection, namely OHL and
oral candidiasis, have been found to occur sooner after HIV seroconversion
than the development of AIDS. Lifson et al (1994) found that within 5 years
after seroconversion,42"/" of the patients in their study developed OHL.
This retrospective analysis of OHL in South Australian HIV-infected patients
found that 5 years after estimated seroconversion, the cumulative
prevalence of OHL was 47.4"/", a finding consistent with the previous study
by Lifson et al (1994). Although not statistically significant, the present study
also found a slight increase in the prevalence of OHL after a period of
infection with HIV that was greater than or equal to 10 years, in this instance
OHL was found in 55.6% of patients.
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5.1.3 Presence of Oral Hairy Leukoplakia and A|DS-defining illnesses
Extensive OHL has been reported in two studies where it occurred
concurrently with an AIDS-defining illness. Kabani et al (1989) described
extensive OHL in a patient four months after they developed KS and PCP.
Southam et al(1992) reported a case where OHL occurred in the epithelium
actually overlying KS lesions in the oral cavity.
The present study examined current or previous AIDS-defining illnesses
relative to the prevalence of OHL. Only 36 out of the 197 patients were
identified as having had an illness that was AIDS defining. ln this group of
patients the prevalence of OHL was 52.8%. The prevalence of OHL in the
161 patients without any reported AIDS-defining condition was 43.5%.
There was no statistical significance in the prevalence of OHL between
these two groups.
ln relation to single AIDS-defining illnesses it was not possible to draw any
conclusions regarding their relationship to the presence of OHL because of
the low patient numbers.
5.1.4 Presence of Oral Hairy Leukoplakia and systemic medication
One hundred and fifty eight patients were taking medication of some kind
either for the treatment of HIV infection, the treatment of oppoftunistic
infections or for the prophylaxis of opporlunistic infections.
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Opportunistic infections for which prophylactic therapy is required include
PCP, MAC, and CMV infections. lt is important to note that these
opportunistic infections are generally seen in patients with advanced
immune deficiency, that is, where CD4+ T-lymphocyte counts are less than
2OO cells/pl (Stewart, 1993; Peiperi, 1995).
The prevalence of OHL in patients who were taking medication was 48.7%.
This figure is only very slightly higher than the overall prevalence of 45.2"/"
for the sample as a whole. However, although slight, this higher prevalence
may be a reflection of more advance immune deficiency in some of these
patients.
Some studies have reported a resolution of OHL following the
commencement of antiviral medication (Newman and Polk, 1987; Resnick
et al, 1988; Phelan and Klein, 1988). This finding would be expected
because of the close association of OHL with Epstein-Barr virus and its
possible role in the pathogenesis of the lesion.
Newman and Polk (1987) described a patient with severe OHL which
resolved after undergoing treatment with an antiviral drug( 9-(1,3-dihydroxy-
2-propoxymethyl) guanine) that was being trialed for use as a treatment for
CMV retinitis. This drug is now used routinely for the treatment of CMV
retinitis and is called ganciclovir. Three of the patients in the present study
were taking ganciclovir. ln one patient's records it was noted that their OHL
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resolved at the time of commencing ganciclovir therapy. The behaviour of
the OHL was not recorded in the records of the second patient, whilst the
third did not have OHL.
Resnick et al (1988) described the regression of OHL following the use of
aciclovir in 5 out of 6 patients who had clinical and histological evidence of
OHL. The use of intravenous aciclovir as a potential treatment for OHL has
also been repofted, resulting in resolution of OHL until cessation of the
treatment (Schöfer et al, 1987). Although the response OHL to various
drugs is interesting as far as the behaviour of the lesion is concerned,
treatment of OHL is not generally required because of the asymptomatic
nature of the lesion.
Forty nine patients in the present study were taking aciclovir. The
prevalence of OHL in this group was 28.1% which is statistically significant
compared to the prevalence of OHL in patients who were not taking
aciclovir. Given the role of EBV in the pathogenesis of OHL, it follows that
aciclovir should have some impact on the prevalence of the lesion. This
drug has been shown to stop EBV production by inhibiting the EBV DNA
polymerase enzyme (Elion, 1982).
Antiretroviral drugs have also been reporled to result in resolution of OHL.
Phelan and Klein (1988) presented a case report of a patient who had a 10
month history of continuous OHL. Within six weeks of treatment with AZT
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for HIV infection, the OHL had completely resolved. AZT was the only
medication that this patient had taken. OHL did not recur in this patient on
cessation of AZT.
Ninety one patients in the present study were taking AZT and again the
prevalence of OHL was reduced compared to the overall prevalence in the
total sample population. The prevalence of OHL in patients taking AZT was
297% compared to an prevalence of OHL oÍ 57.5"/" in patients who were
not taking AZT. This was statistically signif icant (0.001 <P<0,01 , Chi squared
analysis). Other antiretroviral drugs taken by patients in this study were ddl
and ddC. These medications belong to the same class of drug as AZT (that
is, nucleoside analogues) and the prevalence of OHL was also reduced in
patients taking these medications. However patient numbers were too low to
draw any conclusions.
The reduced prevalence of OHL in these patients taking antiretrovirals may
be a result of direct action by the drug. This is especially likely in the case of
aciclovir and ganciclovir which are drugs directed at herpes viruses. EBV is
a member of the herpes virus family. Alternatively, the patients' immune
function may be improved by antiviral medication thereby enabling a more
effective immune response to EBV, thus reducing viral replication. Although
these drugs definitely have a beneficial effect on OHL lesions, the results of
the present study indicate that there must be other factors that lead to the
development of OHL. lt is therefore supposed that the pathogenesis of OHL
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is multifactorial and that viruses, namely EBV are probably co-factors in the
development of OHL
Thirty-nine patients were not taking any medication and the prevalence of
OHL in this group was 30.8%. The lower prevalence of OHL than that found
in the group of patients taking medication may reflect the fact that the
patients not on medication were healthier in terms of their immune function.
5.1.5 Presence of Oral Hairy Leukoplakia and CD4+T-lymphocyte
counts
CD4+T-lymphocyte counts have been used to monitor the health of patients
with HIV infection to give an indication of HIV disease progression. CD4+ T-
lymphocyte counts also help predict the development of opportunistic
infections (Stewart, 1993A; Dwyer et al, 1996). OHL also plays a role in the
staging of HIV infection. lt is included in the Centers for Disease Control and
Prevention (CDC) classification of HIV infection (Appendix l)'
Reichart et al (1989) found in a study of 95 H|V-infected patients who had
clinical and histological evidence of OHL that the average CD4+ T-
lymphocyte count was 149 cells/pl (range 1O-47O cells/pl). Glick et al
(1994) found that, in patients with OHL, the mean CD4+ T-lymphocyte count
was 143.3 cells/pl. The same study reported that the presence of OHL in
HIV positive patients had a positive predictive value of 70.1"/"Thal the CD4+
T-lymphocyte count would be less than 200 cells/pl. Begg et al (1996)
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found a significant association between a low level of CD4+ T-lymphocytes
and OHL in intravenous drug users.
A chronological model of HIV disease progression has been illustrated by
Stewart (1993) in which CD4+ T-lymphocyte counts and opportunistic
infections associated with HIV are correlated. According to this model, oral
manifestations of HIV infection are more likely to occur at an intermediate
level of immunodeficiency where CD4+ T-lymphocytes are between 200-
500 cells/pl.
ln the present study, it was interesting to note that the range of CD4+ T-
lymphocyte counts was very broad both in the group of patients without
OHL (0-2200 cells/pl ) and in the group of patients with OHL (0-1200
cells/pl). This was also repofted by Lifson et al (1994). The mean CD4+ T-
lymphocyte count for patients with OHL in the present study was 294.01
cells/pl which is in accordance with the model proposed by Stewart (1993).
The mean CD4+ T-lymphocyte count in patients without OHL was 376.99
cells/pl.
Ravina et al (1996) found that patients who had OHL demonstrated a
greater decline in CD4+ T-lymphocytes over an eight year period compared
with H|V-infected patients without OHL. This is also inferred by the results of
the present study by determining CD4+ T-lymphocyte counts and presence
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of OHL after placing the patients into groups according to the length of time
since esti mated seroconversion.
At less than 5 years since estimated seroconversion, the CD4+ T-
lymphocyte count for patients with OHL was 303.14 cells/pl compared with
400.18 cells/pl in patients without OHL. When the time since estimated
seroconversion was greater than 10 years, the CD4+ T-lymphocyte counts
in patients with OHL was 174.85 cells/pl compared to 345.60 cells/pl in
patients without OHL. The exception that was found in this study was that in
the group of patients who had seroconveded between 5 and 10 years
previously, the CD4+ T-lymphocyte counts were reversed, that is, they were
higher in patients with OHL (404.03 cells/pl) than in patients without OHL
(385.21 cells/pl).
The results from this study do not demonstrate any statistically significant
relationship between the presence of OHL and CD4+ T-lymphocyte count.
This supports the original hypothesis that in this Australian group of patients
the presence of OHL was not associated with a lower CD4+ T-lymphocyte
count. Further detailed longitudinal studies of patients would provide more
accurate information relating to this. Also, it would be interesting to observe
how the presence of OHL relates to HIV viral load.
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5.1.6 Presence of Oral Hairy Leukoplakia and oral Candida infection
Candida albicans is the most common species of Candida that is found in
the oral cavity (Scully et al, 1994). Oral candidiasis is the most frequently
found oral fungal disease and is seen in both acute HIV infection and in
later stages of the disease process (Greenspan and Greenspan, 1996).
Ramírez-Amador et al (1996) found the prevalence of oral candidiasis in
H|V-infected populations to be approximately 20"/". Other studies have also
reported similar results (Kolokotronis ef al, 1994). The overall prevalence of
oral candidiasis in the present study was 27"/". Lifson et al (1994) found that
the prevalence of oral candidiasis increased as the length of time from HIV
seroconversion increased. This was also the situation with OHL.
Greenspan et al(1984) reporled lhal. Candida was associated with OHL in
26 out of 37 patients in their initial description of OHL. Schiødt et al (1987)
found that 50% of patients with OHL in their study had evidence of Candida.
Other studies have also found a high proportion of Candida associated with
OHL (Kanas ef a/, 1988; Kratochvil et al, 1990; Schulten ef a{ 1991).
Although in the present study it was impossible to determine whether cases
of oral candidiasis were directly associated with OHL, the prevalence of oral
candidiasis was increased in the group of patients who had OHL compared
to the overall prevalence of oral candidiasis. ln patients with OHL, the
prevalence of oral candidiasis was 315% compared lo 27"/" overall. This
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possibly reflects the fact that OHL provides a suitable environment for
Candida organisms to colonise.
Conversely, in the 53 patients who had oral candidiasis, 53% had OHL
present also. This prevalence of OHL is higher than that in the overall
population in this study. This may indicate lhal Candida may, in some way,
help to promote the development of OHL, although studies have shown that
OHL is not affected by antifungal medication. Alternatively, it may reflect the
fact that patients with oral candidiasis have reduced immune function




5.2 Prospective analvsis of Oral Hairv Leukoplakia
The definitive diagnosis of OHL, according to the EC-Clearinghouse
classification of oral lesions in HIV infection, requires demonstration of
Epstein-Barr virus in the lesions (EC-Clearinghouse, 1993). Direct
examination of OHL lesions in this part of this study provided the
opportunity to satisfy these criteria.
5.2.1 Clinical appearance and location of Oral Hairy Leukoplakia
ln 19 patients, lesions were present on the lateral border of the tongue
which had clinical appearances consistent with OHL as repofted in the
literature (Greenspan et al, 1984; Greenspan et al, 1990; ltin and Rufli,
1992). ln the majority of patients the lesions were unilateral, a feature that
does not concurwith the findings of SchiødI et al(1987) who reported that
OHL usually occurred bilaterally.
One patient presented with an unusual fixed, white lesion on their palate.
This lesion did not respond to antifungal treatment and was included as a
possible atypical presentation of OHL. OHL has been previously repofted
involving the soft palate (Kabani et al, 1989). An alternative aetiologic agent
for this lesion could be human papillomavirus (HPV). HPV has been
implicated in a variety of oral lesions including viral wafts, focal epithelial
hyperplasia and squamous cell carcinoma.
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5.2.2 Association between the size of Oral Hairy Leukoplakia lesions
and concurrent medication
The reported beneficial effect of antiviral medication such as AZT and
aciclovir on OHL (Resnick et al, 1988; Phelan and Klein, 1988) was not
evident in this small group of patients. Nine patients were taking
combinations of antiretroviral medication (eg. AZT, ddl, ddO, 3TC, d4T,
indinavir), four of these patients were also taking aciclovir, whilst one patient
was taking aciclovir alone.
The size of OHL lesions has been shown to vary within individual patients.
ln some cases, lesions have been observed to completely disappear and
then recur f rom one examination to the next (Lifson et al, 1994). This could
possibly be due to changes in HIV viral load or possibly even medication. ln
the present study, the area of the tongue covered by the lesions was
recorded and compared between the groups of patients on antiviral
medication and those not on medication. The average area of the tongue
covered by OHL was 277.}mm' in patients who were not taking any antiviral
medication, whilst the area involved in patients on antiviral medication was
slightly higher, 333.3mm2. lf antiviral medication was to have an influence
on the development of OHL, one would expect an absence of OHL or
decreased size of lesions in those patients taking antiviral medication
compared to those not taking antiviral medication. However, the number of
patients was small which limits the interpretation of the results. Alternatively,
the size of OHL lesions may not be influenced by the antiviral medication at
all and simply reflect that those patients who required this medication,
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whether to treat the HIV or opportunistic diseases, have more advanced
HIV disease or are more immunocompromised.
5.2.3 Relationship between the size of Oral Hairy Leukoplakia lesions
and CD4+ T-lymphocyte count
The commonly accepted notion is that OHL is a lesion that is associated
with intermediate immunodeficiency, that is, CD4+ T-lymphocyte count
between 200-500 cells/pl (Stewarl, 1993). The average CD4+ T-
lymphocyte count in this group of 20 patients had lesions was consistent
with this at 323.65 cells/pl. The range of CD4+ T-lymphocyte counts in this
group, however, was varied, ranging from 4 - 1000 cells/pl. This concurred
with the results of the retrospective analysis where a large range in the
CD4+ T-lymphocyte count was also observed in patients where OHL lesions
were present.
It was interesting to determine whether CD4+ T-lymphocyte count
influenced the size of the OHL lesions. Essentially, no difference was
observed in the size of OHL lesions between patients with <200 cells/pl,
200-500 cells/pl or >5OO cells/pl, the areas being 338.83mm', g72.5mm'
and 363.25mm2 respectively. This supports the initial hypothesis that CD4+
T-lymphocyte counts are not associated with the presence of OHL. ln
addition, other studies have reported that the severity of OHL has not been
associated with progression of HIV disease, that is, the development of
AIDS (Schiødt et al, 1987; Kabani et al, 1989).
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5.2.4 Cytology of Oral Hairy Leukoplakia
Examination of exfoliative cytology smears using light microscopy and
electron microscopy demonstrated features similar to those found in other
international studies of OHL.
5.2.4.1 Light Microscopy
There have been numerous reports of the histological features of OHL
documented (Greenspan et al, 1984; Schiø dl et al, 1987; Kanas et al, 1988;
Greenspan et al, 1989). The characteristic histology of OHL is that of
epithelial hyperplasia with hyperparakeratosis and acanthosis. ln addition to
this, ballooning degeneration of epithelial cells is seen in the upper pafi of
the prickle cell layer resulting in a koilocyte-like appearance. lnflammation is
minimal or rarely seen in association with the lesions.
Because of its benign nature, biopsies of OHL are not always indicated
because presumptive diagnosis is usually adequate from a clinical
management perspective. In addition it is often difficult to get a patient to
consent to a biopsy especially in this group of patients who are often
subjected to numerous other invasive diagnostic procedures. Exfoliative
cytology Smears, therefore, are a convenient non-invasive method to
examine OHL lesions.
106
5.2.4.1.1 Haematoxylin and Eosin stain
Migliorati et al (1993) examined the possibility of diagnosing OHL using
exfoliative cytology smears stained with Papanicolaou (PAP) stain' The
specimens in the study by Migliorati el a/ demonstrated numerous epithelial
cells and bacteria. The cells had round to oval basophilic nuclei. ln some
cases the nuclei demonstrated prominent margination of nuclear chromatin,
referred to aS nuclear beading. These features were deemed to be
characteristic of OHL as they were not observed in any of the control
groups.
Epstein et at (1995) also obserued these nuclear changes in PAP stained
cytologic smears of OHL. The latter study found, that of 30 specimens, 16
showed margination of nuclear chromatin'
The present study, in which cytologic smears were stained with H and E,
large numbers of pale staining squamous epithelial cells were observed.
The cells contained basophilic round to oval nuclei as seen in the previous
studies. Margination of nuclear chromatin material or nuclear beading was
not readily apparent in the majority of cells that were seen. Occasional cells
showed evidence of this type of nuclear change.
Some studies have reported the presence of Cowdry{ype inclusion bodies
in the cells which are characteristic in cells infected by herpes viruses
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(Migliorati et al, 1993). However they were not evident in the cytology
smears examined in the present study.
5.2.4.1.2 Periodic Acid - Schiff stain
Candida has regularly been found in association with OHL since its initial
description by Greenspan et al (1984). ln that initial report of OHL, Candida
was found in 26 out of 37 cases (70%). Similar high prevalences oÍ Candida
association with OHL have been found in other studies (Schiødt et al, 1987;
Kanas et a/,1988). The prevalence of Candida organisms found in
association with OHL in the present group of patients was only 25"/" on
examination of PAS-stained cytologic smears. This low prevalence could
possibly be attributed to the small sample size in this part of the present
study. A limitation that was evident in the use exfoliative cytology specimens
were variations in sampling. lt was found that patients with fungal organisms
present by light microscopy did not always have fungal organisms present
according to ultrastructural examination of the cytology smears (Section
5.2.4.2.1) and vice versa.
5.2.4.1 .3 ImmunohistochemistrY
EBV has been consistently found in association with OHL since its
identification in the lesions by Greenspan et al, (1985). lt has since become
the definitive criterion that is required for the diagnosis of OHL (EC-
Clearinghouse, 1993).
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ln this study, two monoclonal antibodies specific for EBV were used to label
the epithelial cells from exfoliative cytology specimens. These antibodies
were for the latent membrane protein (LMP-1) and diffuse early antigen
(EA-D). None of the smears from 13 patients labelled with LMP-1
demonstrated any evidence of positive labelling.
The presence of LMP-1 in OHL lesions is contentious. lt has been
postulated that the expression of this antigen may play a role in the
development of the characteristic histology that is seen in OHL as it has
been shown to inhibit human epithelial cell differentiation and induce
epithelial hyperplasia (Dawson et al, 1990; Wilson et al, 1990). There are
few studies which have investigated the immunohistochemical profile of
OHL (Kanas ef a/, 1988; Zhang et al, 1988; Murray et a/, 1996). Niedobitek
et al(1991) found no evidence of LMP-1 expression in OHL lesions using rn
srTu hybridisation. Thomas et al (1991), who also used /n silu hybridisation,
did find evidence of LMP-1 in 2 out of 11 OHL biopsies. Murray ef a/ (1996)
concluded that the expression of this protein is not necessary for EBV
replication in OHL lesions.
The expression of EA-D in OHL specimens has been previously
demonstrated by Rabanus et al (1991). ln the present study, positive
labelling for this protein was observed in 8 out of the 13 specimens studied.
Two specimens had insufficient numbers of epithelial cells present and the
remaining 3 appeared to be negative. EA-D is involved in the induction of
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EBV replication and synthesis of viral proteins (Rabanus ef al, 1991). The
negative labelling for EBV EA-D in these 3 lesions may be a reflection of
sampling problems. ln the ultrastructural examination of the epithelial cells
from OHL lesions (Section 5.2.4.2.1) it was found that some, but not all of
the cells demonstrated the presence of herpes{ype virus pafticles in their
nuclei. This feature was also demonstrated in the positive
immunohistochemical smears, some, but not all of the cells demonstrated
positive labelling for EA-D in their nuclei. lt is conceivable that, due to
sampling factors, cells positive for EA-D were not represented in the
negative specimens. ln should be noted that one of the negative specimens
was that taken from a flat, fixed white lesion on the hard palate. This lesion
was investigated on the premise that it represented an atypical example of
OHL. The palatal lesion possibly represented an example of a flat viral wart
caused by human papillomavirus infection. The remaining two negative
specimens in this study may also have represented an alternative pathology
to OHL.
5.2.4.2 Transmission electron microscopy
Numerous ultrastructural investigations of OHL have been undeftaken. The
most striking feature that has been observed is the presence of viral
particles consistent with the herpes virus family. Greenspan ef al (1984)
were the first to obserue and report the presence of herpes-type virus
par.ticles within the nuclei of prickle cells and also within the intercellular
spaces in biopsies of OHL.
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5.2.4.2.1 Cellular morphologY
Aparl from the abundant herpes type viral particles which have been
described in various studies (Greenspan et al, 1984; Belton and Eversole,
1986; El-Labban et al, 1988; Ficarra et al, 1988; Kanas et al, 1988; Reed ef
al 1988; Zhang et al, 1988; Greenspan et al, 1989; Kratochvil ef al 1990;
Epstein et al, 1995) other features have been described in ultrastructural
investigations of OHL.
Belton and Eversole (1986) found Candida albicans organisms present in
the superficial layers of the epithelium. The fungal hyphae were found to be
present extracellularly and intracellularly. This was subsequently reported by
other studies (El-Labban et a\,1988; Zhang et al, 1988).
Fungal organisms were observed in four exfoliative cytology specimens
from patients in the present study. lnterestingly none of these patients had
observable fungal organisms on examination of their PAS stained cytology
smears using light microscopy. ln addition, one patient who had a PAS
stained smear positive for Candida had no evidence of fungal organisms
ultrastructurally. This demonstrates a drawback in the use of exfoliative
cytology in that adequate tissue or cell samples may not be obtained by this
method compared to a biopsy.
Some studies have reported crystalline inclusions and tubular structures
within the epithelial cells (Belton and Eversole, 1986; El-Labban ef al 1988;
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Zhang et al, 1988). Zhang et al (1988) described two structures occurring in
the virus-infected cells. These included 35nm diameter tubules arranged in
parallel bundles. This feature had previously been repofted by Belton and
Eversole (1986). A similar structure was repofted by El-Labban et al (1988).
Another structure was also observed which was composed of undulating
convoluted membranes present close to the nucleus of the cell. The nature
and role of these structures are unclear. El-Labban et al (1988) also
described a multivesicular structure within the cytoplasm of the "koilocyte-
like" cells of OHL. This was characterised by clusters of membrane-bound
vesicles which had an average diameter of 100nm. The authors of this
study postulated that this structure may represent an abnormal form of
microtubule due to HIV infection or may be directly related to EBV infection
because similar structures were observed in the first report of cultured cells
from Burkitt's lymphoma.
Our findings were not consistent with those of the aforementioned studies.
This is possibly because the cells that were obtained by scraping the tongue
are very superficial and have lost features such as their organelles as they
matured through the thickness of epithelium. This accounts for the fact that
the majority of cells in the present study had only a fibrillar cytoplasm with
little evidence of organelles.
Nuclear changes, as reported in other studies (Ficarra et a1,1988; Zhang ef
ã1, 1988; Epstein et al, 1995) such as margination and condensation of
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chromatin and punched out appearances of nuclei were obserued in the
present study.
The use of ultrastructural examination of exfoliative cytology specimens for
the diagnosis of OHL has been investigated as an alternative to biopsying
lesions. Kratochvil et al (1990) found that the predominant feature of the
epithelial cells scraped from OHL lesions was the presence of abundant
virus particles within the cells and in the intercellular spaces. Seven out of
the nine patients in our study had herpes{ype virus present in the epithelial
cells scraped off of OHL lesions. The absence of virus present in the cells of
the remaining patients could be due to sampling difficulties. The present
study tends to confirm the usefulness of TEM examination of cytology
samples in the diagnosis of OHL,
ln the study by Epstein et al (1995) electron microscopy demonstraTed 24
out of 30 specimens to be positive for viral particles and nuclear damage,
compared with 16 specimens that showed signs of nuclear damage (for
example. nuclear beading) with light microscopy. They concluded, therefore,
that EM was a more sensitive and reliable method for diagnosing OHL than
light microscopy.
The limitation of regular TEM examination of the squamous cells from OHL
lesions is that the virus particles cannot be positively identified on the basis
of morphology alone. The viruses present in epithelial cells from OHL
113
lesions have features that are consistent with those of members of the
herpes virus family (Miller, 1995). At present there are eight known viruses
within this family that infect humans. These include Herpes simplex types 1
and 2, Varicella-zoster virus, Cytomegalovirus, Epstein-Barr virus, Human
herpes viruses types 6 and 7 and the recently described Human herpes
virus I which has been shown to have a close association with Kaposi's
sarcoma (Epstein et a\,1995; Orenstein ef a\,1997).
ln this study, distinct herpes-types virus pafiicles were observed but, as
already indicated, the morphologic appearance of virus particles is not
sufficient for identification of specific viruses. Ultrastructural immunolabelling
studies on virus particles from OHL lesions are few in number (Zhang et al,
1988; Rabanus et al, 1991). Zhang et al (1988) demonstrated positive
identification of EBV in OHL lesions using two monoclonal antibodies which
were directed against the EBV capsid and membrane antigen. Rabanus ef
a/ (1991) investigated the subcellular distribution and life cycle of EBV in
keratinocytes from OHL lesions. Three monoclonal antibodies were used in
that study which were directed against EBV membrane antigen
(9p3501220), EBV capsid antigen (VCA) and EBV early antigen D (EA-D).
The study by Rabanus ef a/ (1991) found that EA-D was found principally in
the areas of chromatin that had a "punched out" appearance whilst VCA
was located in close approximation to EBV capsids which appeared to be at
an advanced stage of maturation. Membrane antigen was detected most
abundantly on enveloped EBV capsids.
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Epstein et al (1995) attempted immunohistochemistry using an immunogold
labelling technique on specimens that were processed for ultrastructural
examination. The technique in that study was not found to be effective and
subsequently discontinued. ln that repoft, however, there was no reference
to the type of antibody used nor of the immunogold labelling technique that
was attempted. ln the present study immunogold studies are proceeding in
order to provide fufther evidence that the virus is EBV.
ln the present study, an immunogold labelling technique was used on
exfoliative cytology specimens from 2 patients as a pilot investigation. The
antibody used in this study was a monoclonal antibody specific for the EBV
diffuse early antigen (EA-D) which was also an antibody employed by
Rabanus et al (1991). ln the present study, this antigen was restricted to the
nuclei of the squamous epithelial cells as indicated by the presence of the
gold particles. ln some instances the gold particles seemed to be in close
association with herpes-type virus particles, a feature not observed by
Rabanus et al (1991). ln the latter study, the EA-D antigen was found in the
cell nuclei but appeared to be in close association with the areas of
"punched out" chromatin. The pattern of immunogold labelling obtained with






On the basis of this retrospective and prospective analysis of oral hairy
leukoplakia it is concluded that:
OHL is a common lesion in this South Australian group of HIV infected
patients. ln the 197 patients studied, 45.2"/" had the presence of OHL
reponed in their records. This prevalence is comparable to that found by




o The viral aetiology of OHL, in particular the role of Epstein-Barr virus, is
supported, as in other studies, bY:
. the demonstration of the presence of numerous herpes{ype virions
in the nuclei of squamous epithelial cells
. the demonstration of EBV infection in squamous epithelial cells by
immunohistochemical labelling of exfoliative cytology specimens
. the lower prevalence of OHL in patients who were taking antiviral
medication, in particular, aciclovir and AZT
ln this study, the presence of OHL, was not correlated with low CD4+T-
lymphocyte counts nor was its prevalence increased in patients who had
concurrent or previous AIDS-defining illness and who were therefore
potentially more immunocompromised. The presence of OHL, according
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to these results, does not appear to be an indicator of HIV disease
progression or of poor prognosis. The results of this study, however, were
not based on longitudinal data. Although no relationship between CD4+
T-lymphocyte count and OHL was established by this project, it would be
interesting to conduct a longitudinal study of the oral manifestations of
HIV infection, in particular OHL, especially in relation to the new marker
of HIV replication, HIV viral load.
This project provided substantial information on an oral manifestation of HIV
infection that, although well described in the literature, had not been
previously described in an Australian HIV-infected population. Fufiher






1993 Revised Classification Svstem for HIV Infection and Exoanded
Surveillance Gase Definition for AIDS Amonq Adolescents and Adults
CD4+ T-lymphocyte Cateqories:
Category 1 - > 500 cells/pL
Category 2 - 2OO-499 cells/¡rL
Category 3 - <200 cells/pl
Clinical Cateqories:
Category A
. asymptomatic HIV infection
. persistent generalised lymphadenopathy
o acute HIV infection
Category B - Symptomatic conditions not included in Category C
Examples include, bacillary angiomatosis; oropharyngeal candidiasis, vulvovaginal
candidiasis; cervical dysplasia; cervical carcinoma in situ; constitutional symptoms
>1 month duration; oral hairy leukoplakia; herpes zoster; idiopathic
thrombocytopaenic purpura; listeriosis; pelvic inflammatory disease; peripheral
neuropathy
Category C - AIDS defining illnesses
Candidiasis, bronchi, trachea, lungs, oesophagus; invasive cervical cancer;
disseminated or extrapulmonary coccidioidomycosis; extrapulmonary
cryptococcosis; chronic intestinal cryptosporidiosis; cytomegalovirus disease (other
than liver, spleen or nodes); cytomegalovirus retinitis (with loss of vision); HIV-
related encephalopathy; chronic herpes simplex infection; disseminated or
extrapulmonary histoplasmosis; chronic intestinal isosporiasis; lymphoma,
Burkitts's, immunoblastic, primary brain; disseminated or extrapulmonary
Mycobacterium avium complex or M. kansasii; M. tuberculosls; other species of
Mycobacterium, disseminated or extrapulmonary; Pneumocystis cariniipneumonia;
recurrent pneumonia; progressive multifocal leukoencephalopathy; recurrent
Salmonella septicaemia; toxoplasmosis, brain; HIV wasting syndrome
43, 83 and C3 meet the immunologic criteria for AIDS, whilst C1 , C2 and C3 meet
the clinical criteria for AIDS.
Adapted from "CDC. "1993 Revised Classification System for HIV lnfection and
Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults"
M MW R, 1 992:41 (R R-1 7);1 -35"
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APPENDIX II
VIRAL TAXO OMY OF THE FAMILY H PESVIRIDAE
Subfamilv Genus Representative species pathoqenic for humans
Alphaherpesvirinae Simplexvirus Human herpes virus 1
(herpes simplex virus type 1)
Human herpes virus 2
(herpes simplex virus type 2)
Varicellovirus Human herpes virus 3 (Varicella-zoster virus)
Betaherpesvirinae Cytomegalovirus
Roseolovirus
Human herpes virus 5 (Cytomegalovirus)
Human herpes virus 6
(Human B lymphotropic virus)
Human herpes virus 7
Gammaherpesvirinae Lymphocryptovirus Human herpes virus 4 (Epstein-Barr virus)
Human herpes virus 8
(Kaposi's sarcoma associated herpes virus)







THtr .qIG NIFICA Nctr otr oRAl HAIRY LEU KOPI AKIA AND THtr
PREVALEN CE OF EPSTEIN-BAR VIRUS IN LESIONS OF A SO IJTH
AUSTRALIAN POPULATION
Oral Hairy Leukoplakia (OHL) is a white lesion found on the sides of the
tongue and occasionally other areas of the mouth. lt is found in
approximately a quarter of HIV infected patients as well as some organ
transplant recipients whose immune systems are affected by their
treatment. OHL does not cause any significant problems and does not
require treatment. Questions have been raised as to whether or not the
presence of OHL may be a useful indicator in the management of HIV
infection.
Numerous causes of OHL have been suggested, these include Candida,
Human Papillomavirus (HPV) and Epstein-Barr virus (EBV). The exact
cause, at this stage, remains unclear.
Your parlicipation in the study involves a normal clinical examination. Also,
samples will be collected from OHL lesions that are present by gently
scraping the tongue with an instrument. This is entirely painless. These
samples will be used to try and detect the presence of Candida and EBV.
Your participation in the project is entirely voluntary, all the data that is
collected is recorded onto a computer and is strictly confidential. All
information will be analysed anonymously.
The results of the study will help to find out more about oral hairy
leukoplakia and its relevance to HIV infection'
lnvestigators:






THE UN¡VERSITY OF ADELAIDE
CONSENT FORM
See also lnformation Sheet attached.
1 print) hereby consent to
take parl in the research project entitled:
THE SIGNIFICANCE OF ORAL HAIRY LEUKOPLAKIA AND THE PREVALENCE OF
EPSTEIN-BARR VIRUS IN A SAMPLE SOUTH AUSTRALIAN POPULATION
2. I acknowledge that I have read the lnformation Sheet entitled
THE SIGNIFICANCE OF ORAL HAIRY LEUKOPLAKIA AND THE PREVALENCE OF
EPSTEIN-BARR VIRUS IN A SAMPLE SOUTH AUSTRALIAN POPULATION
3. I have had the project, so far as it affects me, fully explained to my satisfaction by the
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Haematoxylin and Eosin Stainino Method
(Modified for Cytology Smears)
Staining
Haematoxylin - 4 minutes
Wash running tap water - approximately l minute*
Diffe iation
O.5% Hydrochloric acid - 2 diPs
Blue"
Running water - 10 minutes*
DiluteAlkali -2dips
Eosin - 30 seconds
Differentiation
7Oo/" alcohol for a few dips if required
Dehvdration and cleaninq*
Absolute alcohol - 2 minutes
Absolute alcohol - 2 minutes
Xylol or Clearene or Histoclear - 2 minutes
Xylol or Clearene or Histoclear - 2 minutes*
Mounti rsli
Mount in Depex









2 minutes absolute alcohol
2 minutes absolute alcohol
2. Sections placed in water (taP)
3. Oxidise in 1"/" periodic acid - 5 minutes
4. Rinse in tap water, then in distilled water
5. Place in Schiff's reagent - 15 minutes
6. Rinse for 3 changes of distilled water in coplin jar - 2 minutes (each change)
7. Wash in running water for 10 minutes
8. Counterstain in Haematoxylin for 3 minutes
9. Wash in running water
10. Dip in 0.5% Hydrochloric acid in7O"/" alcohol
11. Wash in running tap water for 5 minutes
12. Alkali - 30 seconds
13. Dehydrate and clear:
2 minutes xylol
2 minutes xylol
2 minutes absolute alcohol
2 minutes absolute alcohol
14. Mount slides in DePex
NB: 1) Control slides are required for PAS staining
2) For cytology smears deceration step can be omitted
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APPENDIX VIII
Avidin-biotin oe dase technioue for immunohistoc mical labellino of
exfoliative cvto soectmens
1. Following formalin fixation, block endogenous peroxidase
with 0.5% HzOz in methanol
2. Apply required pre-treatment for relevant primary antibody.
3. Rinse in phosphate buffered saline (PBS) buffer
4. lncubatein3"/" normal horse serum (NHS)
5. Drain NHS and incubate with primary antibody (room
temperature)
6. Rinse in PBS buffer
7. lncubate with secondary antibodyt
8. Rinse in PBS buffer
9. lncubate with streptavidin peroxidase+, 60 minutes
10 Rinse in PBS buffer











12. Rinse in PBS buffer 2x3min
13. Lightly counter stain with Mayer's haematoxylin
14. Dehydrate, clear and mount
" Primary antibodies
- Latent membrane protein (LMP-1), monoclonal mouse antibody, Dako-
EBV, CS 1-4, Code no. M 897, Dilution 1/200
- Diffuse early antigen (EA-D), monoclonal mouse antibody, NovoCastra
NCL-EADE31, Dilution 1/50
t Secondary antibody - Rabbit antimouse lgG, Dako E0354




Preoaration of cell susoension for ultrastructu examination
Cellular Morphology
Cells suspended in 1% glutaraldehyde in 0.05M sodium cacodylate
buffer (pH = 7.3) for t hour fixation
2. Cells resuspended in 2% osmium tetroxide in 0.05M sodium cacodylate
plus 6% sucrose for t hour
3. Cells resuspended in 100% methanol for t hour
4. Cells resuspended in Spur's Epoxy resin for t hour and embedded in
specimen capsule,
Polymerised at 6OoC overnight




Preparation of cell suspension for ultrastructural examination
(Prior to immunogold labelling)
Cells are suspended in O,5% glutaraldehyde in phosphate buffered
saline (PBS) for t hour fixation at room temperature
2 Cells resuspended in PBS and stored at 4oC
At room temperature:
3. Cells resuspended in 100% methanol for t hour
4. Cells resuspended in L.R. White resin for 2 hours
5. Cells are embedded in 1OmL resin with 1 drop of accelerant and spun in
capsule





Grid floated on a drop of phosphate buffered saline (PBS) with 1%
bovine serum albumin (BSA) (10 minutes)
2. Grid drained on filter paper (done between each step)
3. Grid floated on a drop of antibody (NovoOastra NCL-EADE31) diluted
(1 :10) in PBS with 1% BSA plus 17o Tween 20 detergent (4 hours)
4. Rinsed in PBS (5 minutes)
5. Rinsed in PBS (5 minutes)
6. Rinsed in PBS (5 minutes)
7. Grid floated on a drop of PBS with 1% BSA
8. Grid floated on goat-antimouse gold diluted (1:100) in PBS with 1%
BSA plus 1% Tween 20 detergent
9. Rinsed in PBS (5 minutes)
10. Rinsed in PBS (5 minutes)
11. Rinsed in PBS (5 minutes)
12. Grid floated on distilled water (to remove salt)








Adler-Stofthz K., Ficarra G., Woods K.V., Gaglioti D., DiPietro M., Shillitoe
E.J., "Prevalence of Epstein-Barr virus and human papillomavirus in oral
mucosa of HIV-infected patients" J Oral Pathol Med,1992;21:164-170
Andersen L., Philipsen H.P., Reichart P.4., "Macro- and microanatomy of
the lateral border of the tongue with special reference to oral hairy
leukoplakia" J Oral Pathol Med, 1990; 19:77-80
Barr C.E., "Practical considerations in the treatment of the H|V-infected
patient" Dent Clin North Am,1994; 38: 403-423
Barret A.W., Crutchley AT., Williams DM., "Oral mucosal Langerhans cells"
Crit Rev Oral Biol Med,1996; 76: 36-58
Barrone R., Ficcara G., Gaglioti D., Orsi 4., Mazzolla F., "Prevalence of oral
lesions among HIV-infected intravenous drug abusers and other risk
groups" Orat Surg Oral Med Oral Pathol, 1990; 69: 169-173
Baskin G.8., Roberts E.D., Kuebler D., Martin L.N., Blauw B', Heeney J.,
Zurcher C., "squamous epithelial proliferative lesions associated with
Rhesus Epstein-Barr virus in Simian lmmunodeficiency Virus-infected
Rhesus monkeys" J lnfect Dis, 1995; 172:535-539
Begg M.D., Panageas K.S., Mitchell-Lewis D., Bucklan R.s., Phelan J.s.,
tamêter 1.8., "Oral lesions as markers of severe immunosuppression in HIV
infected homosexual men" Oral Surg Oral Med Oral Pathol Oral Radiol
Endod, 1 996; 82: 276-283
Belton C.M., Eversole L.R., "Oral hairy leukoplakia: ultrastructural features"
J Oral Pathol,1986; 15:493-499
Birek C., Patterson 8., Maximiw W.C., Minden M.D., " EBV and HSV
infections in a patient who had undergone bone marrow transplantation: oral
manifestations and diagnosis by in situ nucleic acid hybridization" Oral Surg
Oral Med Oral Pathol, 1989; 68: 612-617
Boulter A.W., Soltanpoor N., Swan A.V., Birnbaum W., Johnson N., Gee
Teo C., "Risk factors associated with Epstein-Barr virus replication in oral
epithelial cells of H|V-infected individuals" AIDS, 1996; 10: 935-940
Ceballos-Salobreña 4., Aguirre-Urizar J.M., Baga-Sebastian J.V., "Oral
manifestations associated with human immunodeficiency virus infection in a
Spanish population" J Oral Pathol Med,1996; 25: 523-526
134
Centers for Disease Control: "Pneumocystis carinii pneumonia - Los
Angeles", MMWR,1981 ; 30: 303-305
Centers for Disease Control and Prevention: "1993 Revised classification
system for HIV infection and expanded surveillance case definition for AIDS
among adolescents and adults" MMWR,1992;41 (RR-17):1-35
Chang F., Syrjänen S., Kellokoski J., Syrjänen K., "Human papillomavirus
(HpVi infections and their associations with oral disease" J Oral Pathol
Med, 1991 ; 20: 305-317
Coates E., Slade G.D., Goss 4.N., Gorkic E., "Oral conditions and their
social impact among HIV dental patients" Aust Dent J, 1996; 41: 33-36
Coates R.A., Farewell V.T., Raboud J., Read S.E., Klein M., MacFadden
D.K., Calzavara L.M., Johnson J.K., Fanning M.M., Shepherd F.4., "Using
serial observations to identify predictors of progression to AIDS in the
Toronto sexual contact study" J CIin Epidemiol, 1992;45:245-253
Cooper D.A., Gatell J.M., Kroon S., Clumeck N., Millard J., Goebel F., Bruun
¡.lrl., st¡ngl G., Melville R.L., González-Lahoz J., stevens J.W., Fiddian
4.p., "Zidõvudine in persons with asymptomatic HIV infection and CD4+ cell
counts greater than 400 per cubic millimete/' N Engl J Med, 1993; 329:297-
303
Corso 8., Eversole L.R., Hutt-Fletcher L., "Hairy leukoplakia: Epstein-Barr
virus receptors on oral keratinocyte plasma membranes" Oral Surg Oral
Med Oral Pathol,1989; 67: 416-421
cruchley A.T., Williams D.M., Farthing P.M., Lesch c.4., squier c.4.,
"Regional variation in Langerhans cell distribution and density in normal
human oral mucosa determined using monoclonal antibodies against CD1,
HLADR, HLADQ and HLADP" J Oral Pathol Med,1989; 18: 510-516
Cruchley A.T., Murray P.G., Niedobitek G., Reynolds G.M., Williams D.M',
Young L.S., "The expression of Epstein-Barr virus nuclear antigen (EBNA-1)
in orãl hairy leukoplakia" Oral Diseases, 1997;3 (Supplement 1): 5177-
s179
cruz G.D., Lamster 1.8., Begg M.D., Phelan J.A., Gorman J.M., El-Sadr w.,
"The accurate diagnosis of oral lesions in Human lmmunodeficiency Virus
infection - impact 
-on 
medical staging" Arch Otolaryngol Head Neck Surg,
1996; 122: 68-73
Cubie H.A., Felix D.H,, Wray D., "Application of molecular techniques in the
rapid diagnosis of EBV-associated oral hairy leukoplakia" Oral Surg Oral
Med Oral Pathol,1991; 2O:271-274
135
Daniels T.E., "Human mucosal Langerhans cells: postmortem identification
of regional variations in oral mucosa" J lnvest Dermatol, 1984; 82:21-24
Daniels T.E., Greenspan D., Greenspan J.S., Lennette E., Schiødt M',
Peterson V., de Souza Y., "Absence of Langerhans cells in oral hairy
leukoplakia, an AIDS-related lesion" J lnvest Dermatol,1987; 89: 178-182
Dawson C.W., Rickinson 4.8., Young L.S., "Epstein-Barr virus latent
membrane protein inhibits epithelial cell differentiation" Nature, 1990; 344:
777-780
De Souza Y.G., Freese U.K., Greenspan D., Greenspan J.S', "Diagnosis of
Epstein-Barr virus infection in hairy leukoplakia by using nucleic acid
hybidisation and noninvasive techniques" J Clin Microbiol, 1990; 28: 2775-
2778
Dwyer D.E., Adelstein S., Cunningham A.L., Dowton D'N', Merigan T.C.,
"The laboratory monitoring of H lV infection" Med J Aust, 1 996; 1 64: 301 -303
EC-Clearinghouse on oral problems related to HIV infection and WHO
collaborating centre on oral manifestations of the immunodeficiency virus:
Classification and diagnostic criteria of oral lesions in HIV infection. J Oral
Pathol Med, 1993; 22: 289-91
Eisenberg E., Krutchkoff D., Yamase H., "lncidental oral hairy leukoplakia in
immunocompetent persons: a report of two cases" Oral Surg Oral Med Oral
Pathol, 1 992; 7 4: 332-333
Elion G.8., "Mechanism of action and selectivity of acyclovit'' Am J Med,
1982;73(Suppl):7-12
El-Labban N., Rindum J., Nielsen H., Pindborg J.J., "Crystalline inclusions in
epithelial cells of hairy leukoplakia: a new ultrastructural finding" Scand J
Dent Res, 1 988; 96: 353-359
El-Labban N., Pindborg J.J., Rindum J., Nielsen H., "Futther ultrastructural
findings in epithelial cells of hairy leukoplakia" J Oral Pathol Med, 1990; 19:
24-34
Epstein J., Scully C., "Herpes simplex virus in immunocompromiseci
patients: Growing evidence of drug resistance" Oral Surg Oral Med Oral
Path, 1991,72,47-50
Epstein J.8., Sherlock C.H., Wolber R.4., "Hairy leukoplakia after bone
marrow transplantation" Oral Surg Oral Med Oral Pathol, 1993; 75: 690-695
136
Epstein J.8., Fatahzadeh M., Matisic J., Anderson G., " Exfoliative cytology
and electron microscopy in the diagnosis of hairy leukoplakia" Oral Surg
Oral Med Oral Pathol 1995; 79: 564-569
Eversole L.R., Jacobsen P., Stone C.E., Freckleton V., "Oral condyloma
planus (hairy leukoplakia) among homosexual men: a clinicopathologic
study of thirty six cases" Oral Surg Oral Med Oral Pathol, 1986; 61:249-255
Felix D.H., Watret K., Wray D., Southam J.C., "Hairy leukoplakia in an HIV-
negative nonimmunosuppressed patient" Oral Surg Oral Med Oral Pathol,
1992;74:563-566
Felix D.H., Jalal H., Cubie H.4., Southam J.C., Wray D', Maitland N'J.,
"Detection of Epstein-Barr virus and human papillomavirus type 16 DNA in
hairy leukoplakia by in situ hybridisation and the polymerase chain reaction"
J Oral Pathol Med,1993;22:277-281
Ficarra G., Barone R., Gaglioti D., Milo D., Riccardi R., Romagnoli P., Zorn
M., "Oral hairy leukoplakia among H|V-positive intravenous drug abusers: A
clinicopathologic and ultrastructural study" Oral Surg Oral Med Oral Pathol,
1988;65:421-426
Ficarra G., Milani A., Adler-Storthz K., Woods-Francis K., Del Mistro A., De
Rossi A., Riccardi R., Ravina A., De Maio E., "Recurrent oral condylomata
accuminata and hairy leukoplakia: an early sign of myelodysplastic
syndrome in an HlV-seronegative patient" J Oral Pathol Med, 1991; 20:
398-402
Ficarra G., Romagnoli P., Piluso S., Milo D., Adler-Storlhz K., "Hairy
leukoplakia with involvement of the buccal mucosa" J Am Acad Dermatol,
1992;27:855-858
Fraga-Fernandez J., Vicandi-Plaza 8., "Diagnosis of hairy leukoplakia by
exfoliative cytology methods" Am J Clin Pathol,1992;97:262-266
Glick M., Pliskin M.E., "Regression of oral hairy leukoplakia after oral
administration of acyclovit'' Gen Dent, 1990; 38:374-375
Glick M., Muzyka 8.C., Lurie D., Salkin L.M., "Oral manifestations
associated with HlV-related disease as markers for immune suppression
and AIDS" Oral Surg Oral Med Oral Pathol,1994; 77:344-349
Gottlieb M.S., Schroff R., Schanker H.M', Weisman J'D', Fan P.T', Saxon
A.,, " PneLtmocystis carinii pneumonia and mucosal candidiasis in previously
healthy homosexual men. Evidence of a new acquired cellular
immunodeficiency" N Engl J Med,1981; 305: 1 425-143O
137
Gowdy G., Lee R.K., Carpenter W.M., "Treatment of H|V-related hairy
leukoplakia with podophyllum resin 25% solution" Oral Surg Oral Med Oral
Pathol Oral Radiol Endo, 1995; 79 64-67
Green T.L., Greenspan J.S., Greenspan D., DeSouza Y.G', "Oral lesions
mimicking hairy leukoplakia: a diagnostic dilemma" Oral Surg Oral Med Oral
Pathol, 1 989; 67 : 422-426
Greenspan D., Greenspan J.S., Conant M., Petersen v., Silverman S.,
DeSouza Y., "Oral hairy leukoplakia in male homosexuals: evidence of
association with both papillomavirus and a herpes group virus" Lancet,
1984;2:831-834
Greenspan J.S., Greenspan D., Lennette E.T., Abrams D.|., Conant, M.4.,
Petersen V., Freese U. K., "Replication of EBV within the epithelial cells of
OHL, an A|DS-associated lesion" N Engl J Med,19B5; 313: 1564-1571
Greenspafl D., Greenspan J.S., De Souza Y.G., Levy J.4., Ungar A'M.,
"Oral hairy leukoplakia in an HlV-negative renal transplant recipient" J Oral
Pathol Med, 1 989; 18: 32-34
Greenspan D., Greenspan J.S., Hearst N.G., Pan L-Z', Conant M.4.,
Abrams D.L., Hollander H., Levy J.4., "Relation of oral hairy leukoplakia to
infection with the human immunodeficiency virus and the risk of developing
AIDS" J lnfect Dis, 1987; 155: 475-481
Greenspan D, Hollander H., Friedman-Kien A., Freese U.K., Greenspan
J.S., "Oral hairy leukoplakia in two women, a hemophiliac and a transfusion
recipient" J Oral Pathol Med,1989; 18: 23-31
Greenspan J.S., Rabanus. J-P., Petersen V., Greenspan D., "Fine structure
of EBV-infected keratinocytes in oral hairy leukoplakia" J Oral Pathol Med,
1989;18:565-572
Greenspan J.S., Greenspan D., "Oral hairy leukoplakia: diagnosis and
managem enl" Oral Surg Oral Med Oral Pathol, 1989; 67: 396-403
Greenspan D., Schiødt M., Greenspan J.S., Pindborg J.J., "AIDS and the
mouth", 1 990, Munksgaard, Copenhagen
Greenspan D., Greenspan J.S., "significance of oral hairy leukoplakia" Oral
Surg Oral Med Oral Pathol, 1992;73: 151-154
Greenspan D., Greenspan J.S., "HlV-related oral disease" Lancet, 1996;
348:729-33
Itin P.H., Rufli T., "Oral hairy leukoplakia" lnt J Dermatol,1992; 31: 301-306
138
Itin P.H., Bircher A.j., Litzisdorf Y., Rudin C., "Oral hairy leukoplakia in a
child: confirmation of the clinical diagnosis by ultrastructural examination of
exfoliative cytology specimens" Dermatology, 1994; 189: 167-169 (Medline
abstract)
Kabani S., Greenspan D., DeSouza Y., Greenspan J'S., Cataldo E., "Oral
hairy leukoplakia with extensive oral mucosal involvement - repoft of two
cases" Oral Surg Oral Med Oral Pathol, 1989; 67: 411-415
Kanas R.J., Abrams 4.M., Recher L., Jensen J.L., Handlers J.P., Wuerker
R.8., "Oral hairy leukoplakia: a light microscopic and immunohistochemical
study" Oral Surg Oral Med Oral Pathol, 1988; 66: 334-340
Kanas R.J., Abrams 4.M., Jensen J.L., Wuerker R'B', Handlers J.P., "Oral
hairy leukoplakia: ultrastructural obseryations" Oral Surg Oral Med Oral
Pathol, 1 988; 65: 333-338
Kanitakis J., Euvrard S., Lefrancois N., Hermier C, Thivolet J., "Oral hairy
leukoplakia in a H|V-negative renal graft recipien|" Br J Dermatopathol,
1 991 ; 124: 483-486
Katz M.H., Greenspan D., Heinic G.S., Chan 4.K., Hollander H., Chernoff
D., Greenspan J.S., "Resolution of hairy leukoplakia: an observational trial
of zidovudine versus no treatmenl" J lnfect Dis, 1991; 164: 1240-1241
Kieff E., " Epstein-Barr virus
171:1323-1324
new insights" (Editorial) J lnfect Dr's, 1995;
Kolokotronis 4., Kioses V., Antoniades D., Mandraveli K., Doutsos 1.,
Papanayotou P., "lmmunologic status in patients infected with HIV with oral
candidiasis and hairy leukoplakia" Oral Surg Oral Med Oral Pathol, 1994;
78:41-46
Kratochvil F.J., Riordan G.P., Auclair P.L., Huber M.A', Kragel P.J.,
"Diagnosis of oral hairy leukoplakia by ultrastructural examination of
exfoliative cytologic specimens" Oral Surg Oral Med Oral Pathol, 1990; 70:
613-618
Kumar V., Cotran R.S., Robbins S.L., "Basic Pathology" sth Edition, 1992,
W.B. Saunders Company
Laimins L., "Human papillomaviruses target differentiating epithelia for virion
production malignant conversion" Semin Virol, 1996; 7: 305-313
Langford 4., Kunze R., Lobeck H., Pohle H-D., Reichafi P., "Distribution of
cytokeratins in oral cytological smears of H|V-infected patients" J Oral
Pathol Med, 1992; 21: 58-64
139
Laskaris G., Laskaris M., Theodoridou M., "Oral hairy leukoplakia in a child
with AIDS" Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1990; 79:
570-571
Leggott P.J., "Oral manifestations of HIV infection in children" Oral Surg
Oral Med Oral Pathol, 1992;73:187-192
Lifson 4.R., Hilton J.F., Westenhouse J.L., Canchola 4.J., Samuel M.C.,
Katz M.H., Buchbinder S.P., Hessol N.A., Osmond D.H., Sltiboski S., Lang
W., Greenspan D., Greenspan J.S., "Time from HIV seroconversion to oral
candidiasis or hairy leukoplakia among homosexual and bisexual men
enrolled in three prospective cohorts" AIDS,1994; 8:73-79
Lozada-Nur F., Costa C., "Retrospective findings of the clinical benefits of
podophyllum resin 25% solution on hairy leukoplakia - clinical results in nine
patients" Oral Surg Oral Med Oral Pathol, 1992;73: 555-558
Lozada-Nur F., Robinson J., Regezi J.A., "Oral hairy leukoplakia in
nonimmunosuppressed patients: a repoft of four cases" Oral Surg Oral Med
Oral Pathol, 1994;78: 599-602
Luxton J.C., Williams 1., Weller, 1., Crawford D.H., Epstein-Barr virus
infection of H|V-positive individuals transiently suppressed by high-dose
acyclovir treatment" AIDS, 1993; 7: 1337-1343
Mabruk M.J.E.M.F., Flint S.R., Toner M., Balluz 1., Coleman D., Sullivan D.,
Atkins G.J., "ln situ hybridization and the polymerase chain reaction (PCR)
in the analysis of biopsies and exfoliative cytology specimens for the
definitive diagnosis of oral hairy leukoplakia (OHL)" J Oral Pathol Med,
1994;23:302-308
Mabruk M.J.E.M.F., Flint S.R., Toner M., Leonard N., Sheils O., Coleman
D.C., Atkins G.J., "Detection of Epstein-Barr virus DNA in tongue tissues
form AIDS autopsies without clinical evidence of oral hairy leukoplakia" J
Oral Pathol Med,1995; 24: 109-112
Mabruk M.J.E.M.F., Flint S.R., Coleman D., Shiels O., Toner M., Atkins
G.J., "A rapid microwave-in situ hybridization method for the definitive
diagnosis of oral hairy leukoplakia: comparison with immunohistochemistry"
J Oral Pathol Med, 1996; 25: 170-176
Macleod, R.1., Lang L.Q., Soames J.V., "OHL in an HIV negative renal
transplant patient" Br Dent J, 1990; 169: 208-209
McMillan M.D., Boyd N.M., MacFadyen E.E., Ferguson M.M', "Oral hairy
leukoplakia-like lesions in an H|V-negative male: a case report" NZ Dent J,
1989; 85:121-124
140
Melnick S.L., Sherer R., Louis T.4., Hillman D., Rodriguez E.M., Lackman
C., Capps L., Brown L.S. Jr., Carlyn M., Korvick J.4., "Survival and disease
progression according to gender of patients with HIV infection. The Terry
Beirn Community Programs for Clinical Research on AIDS" JAMA, 1994;
272:1915-21
Migliorati C.A., Cale Jones 4., Baughman P.A., "Use of exfoliative cytology
in the diagnosis of oral hairy leukoplakia" Oral Surg Oral Med Oral Pathol,
1993; 76:704-710
Miller D.R., Heard P.L., Cagle M.P., DiMaio D., Ench Y., Morrison D.G',
Eagan P.4., Gulley M.L., Jenson H.8., Moyer M.P. "Absence of a reservoir
of Epstein-Barr virus (EBV) in normal tongue epithelium" J Oral Pathol Med,
1994;23:156-160
Miller M.J., "Viral Taxonomy" Clin Infect Dis, 1995; 21 :279-80
Mims Annual 1994, 18th Edition, May 1994, Australian Edition
Murray P.G., Niedobitek G., Kremmer E., Grässer F., Reynolds G.M.,
Cruchley A., Williams D.M., Müller-Lantzsch N., Young L'S', " ln situ
detection of the Epstein-Barr virus-encoded antigen in oral hairy leukoplakia
and virus-associated carcinomas." J Pathol, 1996: 178: 44 -47
Nagai Y., Takeshita N., Saku T., "Histopathologic and ultrastructural studies
of oral mucosa wiTh Candida infection" J Oral Pathol Med, 1992; 21: 171-
175
Newman C., Polk 8.F., "Resolution of oral hairy leukoplakia during therapy
with 9-(1,3-dihidroxy-2-propoxymethyl) guanine (DHPG)" Ann lntern Med,
1987; 107:348-350
Niedobitek G., Young L.S., Lau R., Brooks L., Greenspan D., Greenspan
J.S., Rickinson A.8., "Epstein-Barr virus infection in oral hairy leukoplakia:
virus replication in the absence of a detectable latent phase" J Gen Virol,
1991; 72: 3035-3046
Orenstein J.M., Alkan S., Blauvelt A., Jeang K-T., Weinstein M.D., Ganem
D., Herndier 8., "Visualization of human herpesvirus type 8 in Kaposi's
sarcoma by light and transmission electron microscopy" AIDS, 1997;11:
F35-F45
Peiperi L., "Current Clinical Strategies: Manual of HIV/AIDS therapy" zno
Edition, 1995, CCS Publishing, USA
Phelan J.4., Klein R.S., "Resolution of oral hairy leukoplakia during
treatment with azidothymidine" Oral Surg Oral Med Oral Pathol, 1988; 65:
717-720
141
Pofter S.R., Luker J., Scully C., Griffiths M.J., "Oral manifestations of a
group of British patients infected with HIV-1" J Oral Pathol Med, 1989; 18:
47-48
Quinn J.W., Benson E.M., "lt is HIV: immediate and long term plans" Med J
Aust, 1 993; 158: 323-326
Raab-Traub N., "Pathogenesis of Epstein Barr virus and its associated
malignancies" Seminars in Virology, 1 996; 7: 315-323
Raab-Traub N., Webster-Cyriaque J., "Epstein-Barr virus infection and
expression in oral lesions" Oral Diseases, 1997;3 (Supplement 1): S164-
s170
Rabanus J-P., Greenspan D., Petersen V., Leser E., Wolf H', Greenspan
J.S., "subcellular distribution and life cycle of Epstein-Barr virus in
keratinocytes of oral hairy leukoplakia" Am J Pathol, 1991 ; 139: 185-197
Ramírez-Amador V., Gonzalez M., de la Rosa E., "Oral lesions in Mexican
H|V-infected patients" J Oral Pathol Med, 1990; 19: 482-485
Ramírez-Amador V.A., Esquivel-PedrazaL., Ponce de León S., "Prognostic
value of oral candidosis and hairy leukoplakia in 111 Mexican HIV-infected
patients" J Oral Pathol Med,1996; 25: 206-11
Ravina A., Ficarra G., Chiodo M.,ltlazzetti M., Romagnani S., "Relationship
of circulating CD4+ T-lymphocytes and p24 anligenemia to the risk of
developing AIDS in H|V-infected subjects with oral hairy leukoplakia" J Oral
Pathol Med,1996; 25: 108-1 1 1
Reed K.D., Fowler C.8., Brannon R.8., "Ultrastructural detection of herpes-
type virions by negative staining in oral hairy leukoplakia" Am J Clin Pathol,
1988;90:305-308
Reed M.F., Scragg M.4., Williams D.M., Soames J.Y.,"ln vivo effects of
Candida albicans products on rat oral epithelium" J Oral Pathol Med, 1990;
19:326-329
Reichaft P.A., Langford A., Gelderblom H.R., Pohle H.D., Becker J., Wolf
H., "Oral hairy leukoplakia: observations in 95 cases and review of the
literature" J Oral Pathol Med 1989; 18: 410-415
Resnick L., Herbst J.S., Ablashi D.V., Atherton S., Frank B', Rosen L.,
Honryitz S.N., "Regression of oral hairy leukoplakia after orally administered
acyclovir therapy" JAMA,1988; 259: 384-388
142
Riccardi R., Pimpinelli N., Ficarra G., Borgognoni L., Gaglioti D., Romagnoli
P., "Morphology and membrane antigens of non-lymphoid accessory cells in
oral hairy leukoplakia" Hum Pathol, 1990; 21:897-904
Rindum J., Schiødt M., Pindborg J., Scheibel E., "Oral hairy leukoplakia in
three hemophiliacs with human immunodeficiency virus infection" Oral Surg
O ral Med Oral Pathol, 1 987 ; 63:437 -440
Schiødt M., Greenspan D,, Daniels T.E., Greenspan J.S,, "Clinical and
histologic spectrum of oral hairy leukoplakia" Oral Surg Oral Med Oral
Pathol, 1 987 ; 64: 7 1 6-720
Schiødt M., Bakilana P.8., Hiza J.R.F., Shao J'F', Mbaga 1., Faber
Vestergaard 8., Nielsen C.M., Lauritzen E., Lerche 8., Kuijlen K., "Oral
candidiasis and hairy leukoplakia correlate with HIV infection in fanzania"
Oral Surg Oral Med Oral Pathol, 1990; 69: 591-596
Schiødt M., Nørgaard T., Greenspan J.S., " Oral hairy leukoplakia in an HIV-
negative woman with Behçet's syndrome" Oral Surg Oral Med Oral Pathol
Oral Radiol Endod,1995; 79: 53-56
Schmidt-Westhausen A., Gelderblom H.R., Reichart P.4., "Oral hairy
leukoplakia in an HlV-negative seronegative heaft transplant patient" J Oral
Pathol Med,1990; 19: 192-194
Schmidt-Westhausen 4., Gelderblom H.R., Hetzer R., Reichaft P.4.,
"Demonstration of Epstein-Barr virus in scrape material of lateral border of
tongue in heart transplant patients by negative staining electron microscopy"
J Oral Pathol Med,1991; 2O:215-217
Schmidt-Westhausen 4., Gelderblom H.R., Neuhaus P., Reichart P.4.,
"Epstein-Barr virus in lingual epithelium of liver transplant patients" J Oral
Pathol Med, 1 993; 22: 274-276
Schöfer H., Ochsendorf F.R., Helm E. 8., Milbradt R., "Treatment of oral
hairy leukoplakia in AIDS patients with vitamin A acid (topically)or with
acyclovir (systemically)" (letter) Dermatologica, 1 987 ; 17 4: 150-1 5 1
Schulten E.A.J.M., ten Kate R.W., van der Waal 1., "Oral manifestations of
HIV infection in 75 Dutch patients" J Oral Pathol Med, 1989; 18: 42-46
Schulten E.A.J.M., Snijders P.J.F., ten Kate R.W., Mullink H., Walboomers
J.M.M., Meijer C.J.L.M., van der Waal 1., " Oral hairy leukoplakia in HIV
infection: a diagnostic pitfall" Oral Surg Oral Med Oral Pathol, 1992;71: 32-
37
143
Sciubba J., Brandsma J., Schwartz M., Barrezueta N., "Hairy leukoplakia:
an AIDS-associated opporlunistic infection" Oral Surg Oral Med Oral Pathol,
1989; 67: 404-410
Scully C., Pofter S.R., Luker J., "An ABC of oral care in patients with HIV
infection" Br Dent J, 1991 ; 173: 149-150
Scully C., El-Kabir M., Samaranayake L.P., "Candida and Oral Candidosis:
a review" Crit Rev Oral Biol Med, 1994; 5:125-157
Sixbey J.W., Davis D.S., Young L.S., Hutt-Fletcher L', Tedder T.F.,
Rickinson 4.8., "Human epithelial cell expression of an Epstein-Barr virus
receptor" J Gen Virol,1987; 68:805-811
Southam J.C., Felix D.H., Cubie H.A., Wray D., "Multifocal hairy leukoplakia
associated with Kaposi's sarcoma" Br Dent J, 1992;172:21-23
Stewart G.J., "The chronology of HlV-induced disease" Med J Aust, 1993;
158: 3-5
Stewarl G.J., "Could it be HIV? - The challenge: clinical diagnosis of HlV"
Med J Aust,1993; 158: 31-34
Su L., Morgan P.R., Thomas J.4., Lane E.8., "Expression of keratin 14 and
19 mRNA and protein in normal oral epithelia, hairy leukoplakia, tongue
biting and white sponge nevus" J Oral Pathol Med, 1993;22: 183-1Bg
Sugihara K., Reupke H., Schmidt-Westhausen A., Pohle H.D., Gelderblom
H.R., Reichart P.A., " Negative staining EM for the detection of Epstein-Barr
virus in oral hairy leukoplakia" J Oral Pathol Med, 1990; 19: 367-7O
Syrjänen S., Laine P., Happonen R-P., Niemelä M., "Oral hairy leukoplakia
is not a specific sign of H|V-infection but related to immunosuppression in
general" J Oral Pathol Med,1989; 18: 28-31
Thomas J.4., Felix D.H., Wray D., Southam J'C., Cubie H'A., Crawford
D.H., "Epstein-Barr virus gene expression and epithelial cell differentiation in
oral hairy leukoplakia" Am J Pathol,1991; 139: 1369-1381
Walling D.M., Clark N.M., Markovitz D'M., Frank T.S', Braun D.K',
Eisenberg E., Krutchkoff D.J., Felix D.H., Raab-Traub N., "Epstein-Barr
virus coinfection and recombination in non-human immunodeficiency virus-
associated oral hairy leukoplakia;' J lnfect Dis,1995; 171:1122-113O
Wanzala P., Manji F., Pindborg J.J., Plummer F., "LoW prevalence of oral
mucosal lesions in HIV-1 seropositive African women" J Oral Pathol Med,
1989; 18: 416-418
144
Williams D.M., Leigh LM., Greenspan D., Greenspan J.S., "Altered patterns
of keratin expression in oral hairy leukoplakia: prognostic implications" J
Oral Pathol Med,1991; 2O: 167-171
wilson J.8., Weinberg w., Johnson R., Yuspa S., Levine A.J., "Expression
of BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice
induces hyperplasia and aberrant expression of keratin 6" CelL 1990; 61:
1315-1327
Wolf H., Haus M., Wilmes E., "Persistence of Epstein-Barr virus in the
Parotid gland" J Virol,1984; 51: 795-798
Zakrzewska J.M., Aly 2., Speight P.M., "Oral hairy leukoplakia in a HIV-
negative asthmatic patient on systemic steroids" J Oral Pathol Med, 1995;
24:282-284
zhang X., Langford A., Becker J., Rabanus J-P., Pohle H-D., Reichaft P,,
Gelderblom H., "Ultrastructural and immunohistochemical findings in oral
hairy leukoplakia" Virchows Archiv A Pathol Anat Histopath, 1988; 412: 533'
542
145
